JELD-WEN Holding (JELD) 10-Q 6 Aug 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 29, 2024	Aug. 02, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 29, 2024
Document Transition Report	false
Entity File Number	001-38000
Entity Registrant Name	JELD-WEN Holding, Inc.
Entity Incorporation, State	DE
Entity Tax Identification Number	93-1273278
Entity Address, Street Name	2645 Silver Crescent Drive
Entity Address, City	Charlotte
Entity Address, State	NC
Entity Address, Postal Zip Code	28273
City Area Code	704
Local Phone Number	378-5700
Title of each class	Common Stock (par value $0.01 per share)
Trading Symbol	JELD
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		84,542,636
Entity Central Index Key	0001674335
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Income Statement [Abstract]
Net revenues	$ 986,016	$ 1,125,767	$ 1,945,142	$ 2,206,289
Cost of sales	795,971	900,212	1,582,517	1,788,947
Gross margin	190,045	225,555	362,625	417,342
Selling, general and administrative	168,450	162,477	351,254	315,240
Restructuring and asset-related charges (Note 16)	16,447	6,812	34,506	16,078
Operating income (loss)	5,148	56,266	(23,135)	86,024
Interest expense, net	16,564	20,854	32,256	42,346
Loss on extinguishment and refinancing of debt (Note 10)	0	0	1,449	0
Other (income) expense, net (Note 18)	(2,488)	2,159	(16,751)	(1,528)
(Loss) income from continuing operations before taxes	(8,928)	33,253	(40,089)	45,206
Income tax expense (Note 11)	9,563	10,751	6,132	14,239
(Loss) income from continuing operations, net of tax	(18,491)	22,502	(46,221)	30,967
Income from discontinued operations, net of tax (Note 2)	0	15,779	0	22,448
Net (loss) income	$ (18,491)	$ 38,281	$ (46,221)	$ 53,415
Weighted average common shares outstanding (Note 14):
Basic (in shares)	85,271,699	84,964,935	85,397,067	84,781,940
Diluted (in shares)	85,271,699	85,764,785	85,397,067	85,417,344
Net (loss) income per share from continuing operations
Basic (usd per share)	$ (0.22)	$ 0.26	$ (0.54)	$ 0.37
Diluted (usd per share)	(0.22)	0.26	(0.54)	0.36
Net income per share from discontinued operations
Basic (usd per share)	0	0.19	0	0.26
Diluted (usd per share)	0	0.18	0	0.26
Net (loss) income per share
Basic (usd per share)	(0.22)	0.45	(0.54)	0.63
Diluted (usd per share)	$ (0.22)	$ 0.45	$ (0.54)	$ 0.63

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (18,491)	$ 38,281	$ (46,221)	$ 53,415
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments, net of tax expense of $58, $572, $1,205 and $1,153, respectively	(3,944)	(8,494)	(22,242)	(321)
Net investment hedge adjustments, net of tax expense of $854 during the three and six months ended July 1, 2023.	0	2,511	0	2,511
Interest rate hedge adjustments, net of tax expense (benefit) of $25, $(774), $110, and $(1,824), respectively	74	(2,276)	326	(5,361)
Defined benefit pension plans, net of tax expense of $7, $13, $9 and $36, respectively	24	34	30	96
Total other comprehensive (loss), net of tax	(3,846)	(8,225)	(21,886)	(3,075)
Comprehensive (loss) income	$ (22,337)	$ 30,056	$ (68,107)	$ 50,340

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Statement of Comprehensive Income [Abstract]
Foreign currency translation adjustments, net of tax expense (benefit)	$ 58	$ 572	$ 1,205	$ 1,153
Net investment hedge adjustments, net of tax expense		854		854
Interest rate hedge adjustments, net of tax (benefit) expense	25	(774)	110	(1,824)
Defined benefit pension plans, net of tax expense	$ 7	$ 13	$ 9	$ 36

CONSOLIDATED BALANCE SHEETS (un

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 212,821	$ 288,312
Restricted cash	818	835
Accounts receivable, net (Note 3)	507,492	516,674
Inventories (Note 4)	487,703	481,451
Other current assets	63,461	71,507
Assets held for sale (Note 17)	145,736	135,563
Total current assets	1,418,031	1,494,342
Property and equipment, net (Note 5)	653,430	644,242
Deferred tax assets	153,662	150,453
Goodwill (Note 6)	381,748	390,170
Intangible assets, net (Note 7)	105,381	123,910
Operating lease assets, net	137,600	146,931
Other assets	38,224	30,077
Total assets	2,888,076	2,980,125
Current liabilities
Accounts payable	310,219	269,322
Accrued payroll and benefits	100,803	132,550
Accrued expenses and other current liabilities (Note 8)	243,366	233,796
Current maturities of long-term debt (Note 10)	35,384	36,177
Liabilities held for sale (Note 17)	7,931	7,064
Total current liabilities	697,703	678,909
Long-term debt (Note 10)	1,179,002	1,190,075
Unfunded pension liability	26,720	26,502
Operating lease liability	113,518	121,993
Deferred credits and other liabilities	95,634	104,831
Deferred tax liabilities	5,474	7,170
Total liabilities	2,118,051	2,129,480
Commitments and contingencies (Note 21)
Shareholders’ equity
Preferred Stock, par value $0.01 per share, 90,000,000 shares authorized; no shares issued and outstanding	0	0
Common Stock: 900,000,000 shares authorized, par value $0.01 per share, 84,511,647 and 85,309,220 shares issued and outstanding as of June 29, 2024 and December 31, 2023, respectively.	845	853
Additional paid-in capital	763,930	752,171
Retained earnings	122,446	192,931
Accumulated other comprehensive loss	(117,196)	(95,310)
Total shareholders’ equity	770,025	850,645
Total liabilities and shareholders’ equity	$ 2,888,076	$ 2,980,125

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - $ / shares	Jun. 29, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	90,000,000	90,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	900,000,000	900,000,000
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares issued (in shares)		85,309,220
Common stock, shares outstanding (in shares)		85,309,220

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY (unaudited) - USD ($) $ in Thousands	Total	Preferred stock	Common stock	Additional paid-in capital	Other additional paid in capital	Other additional paid in capital Employee stock notes	Retained earnings	Accumulated other comprehensive income (loss)	Foreign currency adjustments	Unrealized gain on net investment hedges	Unrealized gain (loss) on interest rate hedges	Net actuarial pension gain
Balance at beginning of period (in shares) at Dec. 31, 2022		0
Balance at beginning of period at Dec. 31, 2022		$ 0	$ 843		$ 735,526	$ (673)	$ 130,486	$ (142,634)
Balance at beginning of period (in shares) at Dec. 31, 2022			84,347,712
Increase (Decrease) in Stockholders' Equity
Shares issued for exercise/vesting of share-based compensation awards (in shares)			792,234
Shares issued for exercise/vesting of share-based compensation awards			$ 8		135
Shares surrendered for tax obligations for employee share-based transactions (in shares)			(91,009)
Shares surrendered for tax obligations for employee share-based transactions			$ (1)		(1,331)
Amortization of share-based compensation					9,685
Net (loss) income	$ 53,415						53,415
Foreign currency adjustments	(321)								$ (321)
Unrealized gain on net investment hedges										$ 2,511
Unrealized gain (loss) on interest rate hedges											$ (5,361)
Net actuarial pension gain	96											$ 96
Balance at end of period at Jul. 01, 2023	782,384		$ 850	$ 743,342	744,015	(673)	183,901	(145,709)
Balance at period end (in shares) at Jul. 01, 2023			85,048,937
Balance at beginning of period (in shares) at Apr. 01, 2023		0
Balance at beginning of period at Apr. 01, 2023		$ 0	$ 849		739,447	(673)	145,620	(137,484)
Balance at beginning of period (in shares) at Apr. 01, 2023			84,916,876
Increase (Decrease) in Stockholders' Equity
Shares issued for exercise/vesting of share-based compensation awards (in shares)			188,206
Shares issued for exercise/vesting of share-based compensation awards			$ 1		135
Shares surrendered for tax obligations for employee share-based transactions (in shares)			(56,145)
Shares surrendered for tax obligations for employee share-based transactions					(869)
Amortization of share-based compensation					5,302
Net (loss) income	38,281						38,281
Foreign currency adjustments	(8,494)								(8,494)
Unrealized gain on net investment hedges										$ 2,511
Unrealized gain (loss) on interest rate hedges											(2,276)
Net actuarial pension gain	34											34
Balance at end of period at Jul. 01, 2023	$ 782,384		$ 850	743,342	744,015	(673)	183,901	(145,709)
Balance at period end (in shares) at Jul. 01, 2023			85,048,937
Balance at beginning of period (in shares) at Dec. 31, 2023	0	0
Balance at beginning of period at Dec. 31, 2023	$ 850,645	$ 0	$ 853		752,844	(673)	192,931	(95,310)
Balance at beginning of period (in shares) at Dec. 31, 2023	85,309,220		85,309,220
Increase (Decrease) in Stockholders' Equity
Shares issued for exercise/vesting of share-based compensation awards (in shares)			846,499
Shares issued for exercise/vesting of share-based compensation awards			$ 9		2,491
Shares repurchased (in shares)	(1,600,000)		(1,600,000)
Shares repurchased			$ (16)				(24,264)
Shares surrendered for tax obligations for employee share-based transactions (in shares)			(44,072)
Shares surrendered for tax obligations for employee share-based transactions			$ (1)		(865)
Amortization of share-based compensation					10,133
Net (loss) income	$ (46,221)						(46,221)
Foreign currency adjustments	(22,242)								(22,242)
Unrealized gain (loss) on interest rate hedges											326
Net actuarial pension gain	$ 30											30
Balance at period end (in shares) at Jun. 29, 2024	0
Balance at end of period at Jun. 29, 2024	$ 770,025		$ 845	763,930	764,603	(673)	122,446	(117,196)
Balance at period end (in shares) at Jun. 29, 2024			84,511,647
Balance at beginning of period (in shares) at Mar. 30, 2024		0
Balance at beginning of period at Mar. 30, 2024		$ 0	$ 859		759,513	(673)	165,201	(113,350)
Balance at beginning of period (in shares) at Mar. 30, 2024			85,901,543
Increase (Decrease) in Stockholders' Equity
Shares issued for exercise/vesting of share-based compensation awards (in shares)			233,168
Shares issued for exercise/vesting of share-based compensation awards			$ 2		479
Shares repurchased (in shares)	(1,600,000)		(1,600,000)
Shares repurchased			$ (16)				(24,264)
Shares surrendered for tax obligations for employee share-based transactions (in shares)			(23,064)
Shares surrendered for tax obligations for employee share-based transactions					(463)
Amortization of share-based compensation					5,074
Net (loss) income	$ (18,491)						(18,491)
Foreign currency adjustments	(3,944)								$ (3,944)
Unrealized gain (loss) on interest rate hedges											$ 74
Net actuarial pension gain	$ 24											$ 24
Balance at period end (in shares) at Jun. 29, 2024	0
Balance at end of period at Jun. 29, 2024	$ 770,025		$ 845	$ 763,930	$ 764,603	$ (673)	$ 122,446	$ (117,196)
Balance at period end (in shares) at Jun. 29, 2024			84,511,647

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (unaudited) (Parenthetical) - $ / shares	Jun. 29, 2024	Dec. 31, 2023	Jul. 01, 2023
Statement of Stockholders' Equity [Abstract]
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01	$ 0.01
Common stock, par value (usd per share)	$ 0.01	$ 0.01	$ 0.01

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023
OPERATING ACTIVITIES
Net (loss) income	$ (46,221)	$ 53,415
Adjustments to reconcile net income to cash provided by (used in) operating activities:
Depreciation and amortization	69,678	71,752
Deferred income taxes	(11,803)	(946)
Net (gain) loss on disposition of assets	(2,755)	129
Adjustment to carrying value of assets	9,193	3,237
Amortization of deferred financing costs	869	1,572
Loss on extinguishment and refinancing of debt	787	0
Loss on foreign currency translation adjustment related to the substantial liquidation of a foreign subsidiary	4,290	0
Stock-based compensation	10,133	9,685
Amortization of U.S. pension expense	0	250
Recovery of cost from receipts on impaired notes	(1,389)	(1,675)
Other items, net	(3,908)	(7,991)
Net change in operating assets and liabilities:
Accounts receivable	(2,250)	(75,949)
Inventories	(14,155)	50,073
Other assets	7,695	6,702
Accounts payable and accrued expenses	19,588	44,476
Change in short-term and long-term tax liabilities	626	(1,359)
Net cash provided by operating activities	40,378	153,371
INVESTING ACTIVITIES
Purchases of property and equipment	(67,839)	(41,951)
Proceeds from sale of property and equipment	4,255	432
Purchase of intangible assets	(6,294)	(4,981)
Recovery of cost from receipts on impaired notes	1,389	1,675
Cash received for notes receivable	2	93
Cash received from insurance proceeds	1,655	3,165
Change in securities for deferred compensation plan	(2,817)	(659)
Net cash used in investing activities	(69,649)	(42,226)
FINANCING ACTIVITIES
Change in long-term debt and payments of debt extinguishment costs	(15,776)	(70,326)
Common stock issued for exercise of options	2,500	143
Common stock repurchased	(24,280)	0
Payments to tax authorities for employee share-based compensation	(866)	(603)
Payments related to the sale of JW Australia	(1,355)	0
Net cash used in financing activities	(39,777)	(70,786)
Effect of foreign currency exchange rates on cash	(6,460)	2,210
Net (decrease) in cash and cash equivalents	(75,508)	42,569
Cash, cash equivalents and restricted cash, beginning	289,147	220,868
Cash, cash equivalents and restricted cash, ending	$ 213,639	$ 263,437

Description of Company and Summ

Description of Company and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 29, 2024
Accounting Policies [Abstract]
Description of Company and Summary of Significant Accounting Policies	Description of Company and Summary of Significant Accounting Policies Nature of Business – JELD-WEN Holding, Inc., along with its subsidiaries, is a vertically integrated global manufacturer and distributor of windows, doors, and other building products that derives substantially all its revenues from the sale of its door and window products. Unless otherwise specified or the context otherwise requires, all references in these notes to “JELD-WEN,” “we,” “us,” “our,” or the “Company” are to JELD-WEN Holding, Inc. and its subsidiaries. Our continuing operations include facilities located in the U.S., Canada, and Europe. Our products are marketed primarily under the JELD-WEN brand name in the U.S. and Canada and under JELD-WEN and a variety of acquired brand names in Europe. Our revenues are affected by the level of new housing starts, residential and non-residential building construction, and repair and remodeling activity in each of our markets. Our sales typically follow seasonal new construction and repair and remodeling industry patterns. The peak season for home construction and remodeling in many of our markets generally corresponds with the second and third calendar quarters, and therefore, sales volume is typically higher during those quarters. Our first and fourth quarter sales volumes are generally lower due to reduced repair and remodeling activity and reduced activity in the building and construction industry as a result of colder and more inclement weather in certain areas of our geographic end markets. Basis of Presentation – The accompanying unaudited consolidated financial statements as of June 29, 2024 and for the three and six months ended June 29, 2024 and July 1, 2023, respectively, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three and six months ended June 29, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or any other period. The accompanying consolidated balance sheet as of December 31, 2023 was derived from audited financial statements included in our Annual Report on Form 10-K. The accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023. On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell our Australasia business (“JW Australia”). On July 2, 2023, we completed the sale. The net assets and operations of the disposal group met the criteria to be classified as “discontinued operations” and are reported as such in all periods presented unless otherwise noted. The consolidated statements of cash flows include cash flows from discontinued operations through the divestiture date of July 2, 2023. See Note 2 - Discontinued Operations for further information. All U.S. dollar and other currency amounts, except per share amounts, are presented in thousands unless otherwise noted. Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more or fewer days included than a traditional 91-day fiscal quarter. Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation, and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in the nature of these estimates. CARES Act – In March 2020, the United States government enacted the CARES Act to provide certain relief as a result of the COVID-19 pandemic. The CARES Act provided for tax relief, along with other stimulus measures, including a provision for an ERC designed to encourage businesses to retain employees during the COVID-19 pandemic. We recorded a receivable for an ERC from the U.S. government of $6.1 million in other income, net in the fourth quarter of 2023. The balance is included in other current assets in the accompanying consolidated balance sheets as of June 29, 2024 and December 31, 2023, respectively. Recent Accounting Standards Not Yet Adopted – In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures . ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the CODM and included within the segment measure of profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the entity’s CODM. ASU 2023-07 will be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023, and interim reporting periods in fiscal years beginning after December 31, 2024. We do not expect the guidance to have an impact on our financial positions and results of operations. We are currently evaluating the impact of this guidance on the Company’s disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . ASU 2023-09 expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted, and should be applied either prospectively or retrospectively. We have not elected to early adopt this standard. We do not expect the guidance to have an impact on our financial positions and results of operations. We are currently evaluating the impact of this guidance on the Company’s disclosures. We have considered the applicability and impact of all ASUs. We have assessed ASUs not listed above and have determined that they were either not applicable or were not expected to have a material impact on our financial statements.

Discontinued Operations

Discontinued Operations	6 Months Ended
	Jun. 29, 2024
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell our Australasia business (“JW Australia”), for a purchase price of approximately AUD $688 million. On July 2, 2023, we completed the sale, receiving net cash proceeds of approximately $446 million, including $3.3 million of cash received from the settlement of certain forward contracts. We have classified the results of operations for the JW Australia reportable segment, together with certain costs related to the sale, as discontinued operations within the consolidated statements of operations for all periods presented. Subsequent to the completion of the sale, we entered into an agreement to provide certain transition services to JW Australia, including providing information technology post-closing services, purchases under a supply agreement, and reimbursement for certain costs to upgrade specific IT systems up to a capped amount. As of June 29, 2024, we had a liability of $4.5 million relating to these matters, which was included in accrued expenses and other current liabilities in our consolidated balance sheet. As of December 31, 2023, our liability relating to these matters was $8.2 million, of which $6.1 million was included in accrued expenses and other current liabilities, and the remaining was included in deferred credits and other liabilities in the accompanying consolidated balance sheet. Components of amounts reflected in the consolidated statements of operations related to discontinued operations are presented in the table, as follows: Three Months Ended Six Months Ended (amounts in thousands) July 1, 2023 July 1, 2023 Net revenues $ 156,206 $ 301,876 Cost of sales 106,186 211,575 Gross margin 50,020 90,301 Selling, general and administrative 28,732 61,477 Restructuring and asset-related charges — — Operating income 21,288 28,824 Interest income, net (414) (685) Other income, net (871) (2,257) Income from discontinued operations before taxes 22,573 31,766 Income tax expense 6,794 9,318 Income from discontinued operations, net of tax $ 15,779 $ 22,448 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows through the divestiture date of July 2, 2023. The following table presents cash flow and non-cash information related to discontinued operations: Six Months Ended (amounts in thousands) July 1, 2023 Depreciation and amortization $ 5,196 Capital expenditures 6,229 Share-based incentive compensation 812 Provision for bad debt 5,062 As of June 29, 2024 and December 31, 2023, the assets and liabilities associated with the court-ordered divestiture of the Company’s Towanda, PA operations (“Towanda”) as described further in Note 21 - C ommitments and Contingencies, qualify as held for sale. Since the Company will continue manufacturing door skins for its internal needs, the divestiture decision did not represent a strategic shift thereby precluding the divestiture as qualifying as a discontinued operation. In addition to the Towanda net assets, we own assets in St. Kitts and Mexico, which are also classified as held for sale in the accompanying consolidated balance sheet as of June 29, 2024. St. Kitts and Mexico collectively had assets held for sale of $4.8 million and liabilities held for sale of $0.2 million at June 29, 2024. As of December 31, 2023, the assets and liabilities classified as held for sale are those of Towanda. As of June 29, 2024 and December 31, 2023, the related assets and liabilities included within the summary below were expected to be disposed of within the next twelve months and are included in assets held for sale and liabilities held for sale in the accompanying consolidated balance sheets. (amounts in thousands) June 29, 2024 December 31, 2023 Assets Accounts receivable, net $ 42 $ — Inventories $ 20,133 $ 17,337 Other current assets 150 108 Property and equipment, net 57,965 50,672 Intangible assets, net 1,471 1,471 Goodwill 65,000 65,000 Operating lease assets, net 975 975 Assets held for sale $ 145,736 $ 135,563 Liabilities Accounts payable $ 65 $ — Accrued payroll and benefits $ 1,239 $ 901 Accrued expenses and other current liabilities 6,610 6,126 Operating lease liability 17 37 Liabilities held for sale $ 7,931 $ 7,064

Accounts Receivable

Accounts Receivable	6 Months Ended
	Jun. 29, 2024
Receivables [Abstract]
Accounts Receivable	Accounts Receivable We sell our manufactured products to a large number of customers, primarily in the residential housing construction and remodel sectors, broadly dispersed across many domestic and foreign geographic regions. We assess the credit risk relating to our accounts receivable based on quantitative and qualitative factors, including historical credit collections within each region where we have operations. We perform ongoing credit evaluations of our customers to minimize credit risk. We do not usually require collateral for accounts receivable, but do require advance payment, guarantees, a security interest in the products sold to a customer, and/or letters of credit in certain situations. Customer accounts receivable converted to notes receivable are collateralized by inventory or other collateral. At June 29, 2024 and December 31, 2023, we had an allowance for credit losses of $9.8 million and $11.3 million, respectively. The decrease in the allowance for credit losses in the six months ended June 29, 2024 was primarily due to decreased sales and an improved portfolio of aged receivables in our North America segment.

Inventories

Inventories	6 Months Ended
	Jun. 29, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor, and manufacturing overhead costs. (amounts in thousands) June 29, 2024 December 31, 2023 Raw materials $ 396,613 $ 404,360 Work in process 20,777 21,141 Finished goods 97,974 84,954 Inventory valuation reserves (27,661) (29,004) Total inventories $ 487,703 $ 481,451 To conform with current period presentation, certain amounts in prior period information have been reclassified.

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended
	Jun. 29, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net (amounts in thousands) June 29, 2024 December 31, 2023 Property and equipment $ 1,966,754 $ 1,966,371 Accumulated depreciation (1,313,324) (1,322,129) Total property and equipment, net $ 653,430 $ 644,242 We recorded accelerated depreciation of our plant and equipment of $5.8 million during the three and six months ended June 29, 2024, and $1.1 million and $3.2 million during the three and six months ended July 1, 2023, respectively, within restructuring and asset-related charges in the accompanying consolidated statements of operations. For more information, refer to Note 16 - Restructuring and Asset-Related Charges. Additionally, we recorded accelerated depreciation of $9.1 million in the three and six months ended July 1, 2023 from reviews of North America equipment capacity optimization. These charges were recorded within cost of sales in the accompanying consolidated statements of operations. The effect on our carrying value of property and equipment due to currency translations for foreign property and equipment, net, was a decrease of $7.2 million as of June 29, 2024 compared to December 31, 2023, respectively. Depreciation expense was recorded as follows: Three Months Ended Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 Cost of sales $ 20,464 $ 30,255 $ 40,462 $ 50,528 Selling, general and administrative 1,127 1,243 2,248 2,888 Total depreciation expense $ 21,591 $ 31,498 $ 42,710 $ 53,416

Goodwill

Goodwill	6 Months Ended
	Jun. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill The following table summarizes the changes in goodwill by reportable segment: (amounts in thousands) North Europe Total Gross carrying amount at December 31, 2023 $ 182,412 $ 268,512 $ 450,924 Foreign currency translation (215) (10,267) (10,482) Gross carrying amount at June 29, 2024 $ 182,197 $ 258,245 $ 440,442 Accumulated impairment losses at December 31, 2023 $ — $ (60,754) $ (60,754) Foreign currency translation — 2,060 2,060 Accumulated impairment losses at June 29, 2024 $ — $ (58,694) $ (58,694) Balance, net of impairment at June 29, 2024 $ 182,197 $ 199,551 $ 381,748

Intangible Assets, Net

Intangible Assets, Net	6 Months Ended
	Jun. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Intangible Assets, Net The cost and accumulated amortization values of our intangible assets were as follows: June 29, 2024 (amounts in thousands) Cost Accumulated Net Customer relationships and agreements $ 121,437 $ (87,021) $ 34,416 Software 69,837 (26,750) 43,087 Trademarks and trade names 31,739 (11,456) 20,283 Patents, licenses and rights 12,638 (5,043) 7,595 Total amortizable intangibles $ 235,651 $ (130,270) $ 105,381 December 31, 2023 (amounts in thousands) Cost Accumulated Net Customer relationships and agreements $ 123,713 $ (84,281) $ 39,432 Software 113,429 (58,424) 55,005 Trademarks and trade names 32,148 (10,802) 21,346 Patents, licenses and rights 12,666 (4,539) 8,127 Total amortizable intangibles $ 281,956 $ (158,046) $ 123,910 We recorded accelerated amortization of $14.1 million during the six months ended June 29, 2024 for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. The expense was recorded within SG&A The effect on our carrying value of intangible assets due to currency translations for foreign intangible assets was a decrease of $0.7 million as of June 29, 2024 compared to December 31, 2023. Amortization expense was recorded as follows: Three Months Ended Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 Amortization expense $ 4,907 $ 5,999 $ 23,823 $ 12,000

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	6 Months Ended
	Jun. 29, 2024
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities (amounts in thousands) June 29, 2024 December 31, 2023 Accrued sales and advertising rebates $ 71,725 $ 82,732 Current portion of operating lease liability 34,101 32,477 Non-income related taxes 23,078 20,072 Current portion of warranty liability (Note 9) 21,928 22,819 Accrued freight 17,674 18,963 Current portion of accrued claim costs relating to self-insurance programs 15,810 14,079 Accrued expenses 14,452 15,758 Current portion of restructuring accrual ( Note 16 ) 12,896 3,375 Current portion of uncertain tax positions (Note 11) 10,638 — Legal claims provision ( Note 21 ) 7,159 2,683 Deferred revenue and customer deposits 6,104 7,189 Accrued income taxes payable 5,416 9,252 Accrued interest payable 1,652 1,401 Current portion of derivative liability (Note 19) 733 2,996 Total accrued expenses and other current liabilities $ 243,366 $ 233,796 The legal claims provision relates primarily to contingencies associated with the ongoing legal matters disclosed in Note 21 - Commitments and Contingencies. The accrued sales and advertising rebates, accrued interest payable, accrued freight, and non-income related taxes can fluctuate significantly period-over-period due to timing of payments.

Warranty Liability

Warranty Liability	6 Months Ended
	Jun. 29, 2024
Product Warranties Disclosures [Abstract]
Warranty Liability	Warranty Liability Warranty terms range from one year to lifetime on certain window and door components. Warranties are normally limited to servicing or replacing defective components for the original customer. Product defects arising within six months of sale are classified as manufacturing defects and are not included in the current period expense below. Some warranties are transferable to subsequent owners and are either limited to 10 years from the date of manufacture or require pro rata payments from the customer. Estimated warranty costs based on historical experience are recorded as a provision at the time of sale. The provision is adjusted periodically to reflect actual experience. An analysis of our warranty liability is as follows: (amounts in thousands) June 29, 2024 July 1, 2023 Balance as of January 1 $ 53,247 $ 52,389 Current period charges 12,740 16,471 Experience adjustments 633 242 Payments (13,307) (15,118) Currency translation (423) 207 Balance at period end 52,890 54,191 Current portion (21,928) (22,788) Long-term portion $ 30,962 $ 31,403 The most significant component of our warranty liability was in the North America segment. As of June 29, 2024, the warranty liability in the North America segment totaled $46.7 million, after discounting future estimated cash flows at rates between 0.53% and 4.23%. Without discounting, the liability would have increased by approximately $3.5 million.

Long-Term Debt

Long-Term Debt	6 Months Ended
	Jun. 29, 2024
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt Our long-term debt, net of original issue discount and unamortized debt issuance costs, consisted of the following: June 29, 2024 June 29, 2024 December 31, 2023 (amounts in thousands) Interest Rate Senior Notes 4.63% - 4.88% $ 600,000 $ 600,000 Term Loan Facility 7.44% (1) 533,569 536,250 Finance leases and other financing arrangements 1.00% - 8.95% (1) 65,204 74,460 Mortgage notes 5.68% - 6.18% (1) 20,748 22,070 Total Debt 1,219,521 1,232,780 Unamortized debt issuance costs and original issue discounts (5,135) (6,528) Current maturities of long-term debt (35,384) (36,177) Long-term debt $ 1,179,002 $ 1,190,075 (1) Term Loan B, mortgage notes and certain finance leases and other financing arrangements are subject to variable interest rates. Summaries of our significant changes to outstanding debt agreements as of June 29, 2024 are as follows: Senior Secured Notes and Senior Notes In December 2017, we issued $800.0 million of unsecured Senior Notes in two tranches: $400.0 million bearing interest at 4.63% and maturing in December 2025 (“4.63% Senior Notes”), and $400.0 million bearing interest at 4.88% and maturing in December 2027 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In May 2020, we issued $250.0 million of Senior Secured Notes bearing interest at 6.25% and maturing in May 2025 (“6.25% Senior Secured Notes”) in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The proceeds were net of fees and expenses associated with debt issuance, including an underwriting fee of 1.25%. Interest is payable semiannually, in arrears, each May and November. On August 3, 2023, we redeemed all $250.0 million of our 6.25% Senior Secured Notes and $200.0 million of our 4.63% Senior Notes. The Company recognized a pre-tax loss of $6.5 million on the redemption in the third quarter of 2023, consisting of $3.9 million in call premium and $2.6 million in accelerated amortization of debt issuance costs. Term Loan Facility U.S. Facility - Initially executed in October 2014, we amended the Term Loan Facility in July 2021 to, among other things, extend the maturity date from December 2024 to July 2028 and provide additional covenant flexibility. Pursuant to the amendment, certain existing and new lenders advanced $550.0 million of replacement term loans, the proceeds of which were used to prepay in full the amount outstanding under the previously existing term loans. The replacement term loans originally bore interest at LIBOR (subject to a floor of 0.00%) plus a margin of 2.00% to 2.25% depending on JWI’s corporate credit ratings. In addition, the amendment also modified certain other terms and provisions of the Term Loan Facility, and adds language to address the replacement of LIBOR with a SOFR basis upon the June 30, 2023 cessation of the publication of LIBOR. Voluntary prepayments of the replacement term loans are permitted at any time, in certain minimum principal amounts, but were subject to a 1.00% premium during the first six months. The amendment requires 0.25% of the initial principal to be repaid quarterly until maturity. In June 2023, we amended the Term Loan Facility to replace LIBOR with a Term SOFR based rate as the successor benchmark rate and made certain other technical amendments and related conforming changes. All other material terms and conditions were unchanged. In January 2024, we amended the Term Loan Facility to lower the applicable margin for replacement term loans, remove certain provisions no longer relevant to the parties, and make certain other technical amendments and related conforming changes. Pursuant to the amendment, replacement term loans bear interest at SOFR plus a margin of 1.75% to 2.00% depending on JWI’s corporate credit ratings, compared to a margin of 2.00% to 2.25% under the previous amendment. All other material terms and conditions of the Term Loan Agreement were unchanged. As a result of this amendment, we recognized debt extinguishment and refinancing costs of $1.4 million, which included $0.8 million of unamortized debt issuance costs and original discount fees. As of June 29, 2024, the outstanding principal balance, net of original issue discount, was $532.9 million . In May 2020, we entered into interest rate swap agreements with a weighted average fixed rate of 0.395% paid against one-month LIBOR floored at 0.00% with outstanding notional amounts aggregating to $370.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. In June 2023, the interest rate swap agreements were amended to convert to a SOFR basis on June 30, 2023, resulting in a weighted average fixed rate of 0.317% paid against one-month USD-SOFR CME Term floored at (0.10)%. The interest rate swap agreements were designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and matured in December 2023. See Note 19 - Derivative Financial Instruments for additional information on our derivative assets and liabilities. In February 2024, we entered into interest rate collar agreements with a cap rate of 4.50% paid against one-month USD-SOFR CME Term floored at 3.982% and 3.895% with outstanding notional amounts aggregating to $100.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. The interest rate collar agreements were designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and mature in February 2026. See Note 19 - Derivative Financial Instruments for additional information on our derivative assets and liabilities. Revolving Credit Facility ABL Facility - Initially executed in 2014, extensions of credit under our ABL Facility are limited by a borrowing base calculated based on specified percentages of the value of eligible accounts receivable and inventory, subject to certain reserves and other adjustments. We pay a fee of 0.25% on the unused portion of the commitments. The ABL Facility has a minimum fixed charge coverage ratio that we are obligated to comply with under certain circumstances. The ABL Facility has various non-financial covenants, including restrictions on liens, indebtedness, dividends, customary representations and warranties, and customary events of defaults and remedies. In July 2021, we amended the ABL Facility to, among other things, extend the maturity date from December 2022 to July 2026, increase the aggregate commitment to $500.0 million, provide additional covenant flexibility, conform certain terms and provisions to the Term Loan Facility, and amend the interest rate grid applicable to the loans thereunder by adding language to address the replacement of LIBOR with a SOFR basis upon the June 30, 2023 cessation of the publication of LIBOR. Pursuant to the amendment, the amount allocated to U.S. borrowers was increased to $465.0 million. The amount allocated to Canadian borrowers was maintained at $35.0 million. Borrowings under the ABL Facility bore, at the borrower’s option, interest at either a base rate plus a margin of 0.25% to 0.50% depending on excess availability or LIBOR (subject to a floor of 0.00%) plus a margin of 1.25% to 1.50% depending on excess availability. All other material terms and conditions were unchanged. In June 2023, we amended the ABL Facility to replace LIBOR with a Term SOFR based rate as the successor benchmark rate and made certain other technical amendments and related conforming changes. All other material terms and conditions were unchanged. As of June 29, 2024, we had no outstanding borrowings, $2.8 million in letters of credit and $478.8 million available under the ABL Facility. Mortgage Notes – In December 2007, we entered into thirty-year mortgage notes secured by land and buildings in Denmark with principal payments which began in 2018. As of June 29, 2024, we had DKK 144.6 million ($20.7 million) outstanding under these notes. Finance leases and other financing arrangements – In addition to finance leases, we include insurance premium financing arrangements and loans secured by equipment in this category. As of June 29, 2024, we had $65.2 million outstanding in this category, with maturities ranging from 2024 to 2031. As of June 29, 2024, we were in compliance with the terms of all of our Credit Facilities and the indentures governing the Senior Notes.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 29, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective income tax rate for continuing operations wa s (107.1)% and (15.3)% for the three and six months ended June 29, 2024, respectively, and 32.3% and 31.5% for the three and six months ended July 1, 2023, respectively. In accordance with ASC 740-270, we recorded an income tax expense of $9.6 million and $6.1 million from continuing operations in the three and six months ended June 29, 2024, respectively, and an income tax expense of $10.8 million and $14.2 million from continuing operations in the three and six months ended July 1, 2023 , respectively. We applied our estimated annual effective tax rate to year-to-date income for includable entities during the respective periods. Entities that are currently generating losses and for which there is a full valuation allowance are excluded from the worldwide effective tax rate calculation and are calculated separately. The impact of significant discrete items is separately recognized in the quarter in which they occur. The tax expense for discrete items included in the tax provision for continuing operations for the three months ended June 29, 2024 was $9.4 million, compared to a tax expense of $1.5 million for the three months ended July 1, 2023. The discrete tax expense amounts for the three months ended June 29, 2024 comprised primarily of $7.7 million of tax expense due to changes in uncertain tax positions relating primarily to a historical income tax audit and $2.2 million attributable to an increase in the valuation allowance recorded against our U.S. state tax attributes due to changes in estimated forecasted earnings. The discrete tax expense amounts for the three months ended July 1, 2023 comprised primaril y of a $1.5 million of tax expense attributable to an increase in the valuation allowance recorded against our state U.S. state tax attributes due to changes in estimated forecasted earnings. The tax expense for discrete items included in the tax provision for continuing operations for the six months ended June 29, 2024 was $12.1 million , compared to a tax expense of $2.6 million for the six months ended July 1, 2023 . The discrete tax expense amounts for the six months ended June 29, 2024 comprised primarily of $9.7 million of tax expense due to changes in uncertain tax positions from ongoing audits and $2.3 million attributable to an increase in the valuation allowance recorded against our tax attributes due to changes in estimated forecasted earnings. The discrete tax expense amounts for the six months ended July 1, 2023 comprised primaril y of $1.5 million of tax expense attributable to an increase in the valuation allowance recorded against our U.S. state tax attributes due to changes in estimated forecasted earnings and $1.2 million of tax expense attributable to share-based compensation. Under ASC 740-10, we provide for uncertain tax positions and the related interest expense by adjusting unrecognized tax benefits and accrued interest accordingly. We recognize potential interest and penalties related to unrecognized tax benefits in income tax expense. As of June 29, 2024 and December 31, 2023, we had a liability for unrecognized tax benefits without regard to accrued interest of $45.3 million and $38.9 million, respectively. As of June 29, 2024, $10.6 of our liability for unrecognized tax benefits without regard to accrued interest was included in accrued expenses and other current liabilities in the accompanying consolidated balance sheet. The U.S. Congress, the Organization for Economic Co-operation and Development (“OECD”), the EU and other government agencies in jurisdictions in which we and our affiliates do business have maintained a focus on the taxation of multinational companies. During 2023, the OECD issued administrative guidance for the Pillar Two Global Anti-Base Erosion rules (“Pillar Two”), which generally imposes a 15% global minimum tax on multinational companies. Many Pillar Two rules are effective for fiscal years beginning on January 1, 2024, with other aspects to be effective from 2025. We regularly monitor developments in our jurisdictions and consider the impact of the tax-related proposals as they arise. We do not expect the minimum tax to have a material impact on our financial statements. As of June 29, 2024 , the Company maintained a partial indefinite reinvestment assertion on its post- 2017 undistributed foreign earnings.

Segment Information

Segment Information	6 Months Ended
	Jun. 29, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information We report our segment information in the same way management internally organizes the business to assess performance and make decisions regarding allocation of resources in accordance with ASC 280-10 - Segment Reporting . Management reviews net revenues and Adjusted EBITDA from continuing operations to evaluate segment performance and allocate resources. We define Adjusted EBITDA from continuing operations as income (loss) from continuing operations, net of tax, adjusted for the following items: income tax expense (benefit); depreciation and amortization; interest expense, net ; and certain special items consisting of non-recurring net legal and professional expenses and settlements; restructuring and asset-related ch arges; M&A related costs; net (gain) loss on sale of property and equipment; loss on extinguishment and refinancing of debt; share-based compensation expense; non-cash foreign exchange transaction/translation (gain) loss; and other special items. We have two reportable segments, organized and managed principally in geographic regions: North America and Europe. We report all other business activities in Corporate and unallocated costs. Factors considered in determining the two reportable segments include the nature of business activities, the management structure accountable directly to the CODM, the discrete financial information regularly reviewed by the CODM, and information presented to the Board of Directors and investors. No operating segments have been aggregated for our presentation of reportable segments. The following tables set forth certain information relating to our segments’ operations: (amounts in thousands) North Europe Total Operating Corporate Total Three Months Ended June 29, 2024 Total net revenues $ 710,651 $ 277,081 $ 987,732 $ — $ 987,732 Intersegment net revenues (52) (1,664) (1,716) — (1,716) Net revenues from external customers $ 710,599 $ 275,417 $ 986,016 $ — $ 986,016 Three Months Ended July 1, 2023 Total net revenues $ 817,184 $ 309,562 $ 1,126,746 $ — $ 1,126,746 Intersegment net revenues (72) (907) (979) — (979) Net revenues from external customers $ 817,112 $ 308,655 $ 1,125,767 $ — $ 1,125,767 (amounts in thousands) North Europe Total Operating Corporate Total Six Months Ended June 29, 2024 Total net revenues $ 1,390,653 $ 556,879 $ 1,947,532 $ — $ 1,947,532 Intersegment net revenues (60) (2,330) (2,390) — (2,390) Net revenues from external customers $ 1,390,593 $ 554,549 $ 1,945,142 $ — $ 1,945,142 Six Months Ended July 1, 2023 Total net revenues $ 1,585,306 $ 622,183 $ 2,207,489 $ — $ 2,207,489 Intersegment net revenues (161) (1,039) (1,200) — (1,200) Net revenues from external customers $ 1,585,145 $ 621,144 $ 2,206,289 $ — $ 2,206,289 Three Months Ended June 29, 2024 (amounts in thousands) North America Europe Total Operating Segments Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 30,717 $ (5,025) $ 25,692 $ (44,183) $ (18,491) Income tax expense (benefit) 12,913 10,300 23,213 (13,650) 9,563 Depreciation and amortization 18,900 7,563 26,463 1,786 28,249 Interest expense, net 616 587 1,203 15,361 16,564 Special items: Net legal and professional expenses and settlements 922 1,119 2,041 18,305 20,346 Restructuring and asset-related charges 9,227 6,669 15,896 551 16,447 M&A related costs (42) — (42) 5,095 5,053 Net gain on sale of property and equipment 287 (159) 128 (18) 110 Share-based compensation expense 1,043 101 1,144 3,930 5,074 Non-cash foreign exchange transaction/translation loss (gain) 228 (2,353) (2,125) 933 (1,192) Other special items 826 1,620 2,446 670 3,116 Adjusted EBITDA from continuing operations $ 75,637 $ 20,422 $ 96,059 $ (11,220) $ 84,839 Three Months Ended July 1, 2023 (amounts in thousands) North America Europe Total Operating Segments Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 51,269 $ 10,656 $ 61,925 $ (39,423) $ 22,502 Income tax expense (benefit) 21,127 3,080 24,207 (13,456) 10,751 Depreciation and amortization (1) 27,699 7,499 35,198 3,016 38,214 Interest expense, net 750 417 1,167 19,687 20,854 Special items: Net legal and professional expenses and settlements 2 2,386 2,388 1,998 4,386 Restructuring and asset-related charges 5,658 515 6,173 639 6,812 M&A related costs 321 — 321 948 1,269 Net loss (gain) on sale of property and equipment 360 (192) 168 — 168 Share-based compensation expense 1,492 484 1,976 2,773 4,749 Non-cash foreign exchange transaction/translation (gain) loss (114) 557 443 4 447 Other special items 254 (1,540) (1,286) 5 (1,281) Adjusted EBITDA from continuing operations $ 108,818 $ 23,862 $ 132,680 $ (23,809) $ 108,871 (1) North America depreciation and amortization expense in the three months ended July 1, 2023 includes accelerated depreciation of $9.1 million from reviews of equipment capacity optimization. To conform with current period presentation, certain amounts in prior period information have been reclassified. Six Months Ended June 29, 2024 (amounts in thousands) North America Europe Total Operating Segments Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 47,002 $ (5,003) $ 41,999 $ (88,220) $ (46,221) Income tax expense (benefit) 20,345 13,158 33,503 (27,371) 6,132 Depreciation and amortization (1) 36,891 15,056 51,947 17,731 69,678 Interest expense, net 1,318 931 2,249 30,007 32,256 Special items: Net legal and professional expenses and settlements 1,717 1,372 3,089 34,447 37,536 Restructuring and asset-related charges 23,125 10,625 33,750 756 34,506 M&A related costs — — — 6,178 6,178 Net gain on sale of property and equipment (2,551) (186) (2,737) (18) (2,755) Loss on extinguishment and refinancing of debt — 1,449 1,449 Share-based compensation expense 2,261 648 2,909 7,224 10,133 Non-cash foreign exchange transaction/translation loss (gain) 262 (3,296) (3,034) 296 (2,738) Other special items 6,465 1,620 8,085 (692) 7,393 Adjusted EBITDA from continuing operations $ 136,835 $ 34,925 $ 171,760 $ (18,213) $ 153,547 (1) Corporate and unallocated depreciation and amortization expense includes software accelerated amortization of $14.1 million for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. Six Months Ended July 1, 2023 (amounts in thousands) North America Europe Total Operating Segments Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 86,518 $ 17,955 $ 104,473 $ (73,506) $ 30,967 Income tax expense (benefit) 35,660 4,495 40,155 (25,916) 14,239 Depreciation and amortization (1) 45,497 14,932 60,429 6,128 66,557 Interest expense, net 3,584 545 4,129 38,217 42,346 Special items: Net legal and professional expenses and settlements 2 2,456 2,458 3,750 6,208 Restructuring and asset-related charges 13,470 1,782 15,252 826 16,078 M&A related costs 567 — 567 3,402 3,969 Net loss (gain) on sale of property and equipment 384 (297) 87 — 87 Share-based compensation expense 2,452 983 3,435 5,438 8,873 Non-cash foreign exchange transaction/translation (gain) loss (299) (1,151) (1,450) 282 (1,168) Other special items 181 (201) (20) 52 32 Adjusted EBITDA from continuing operations $ 188,016 $ 41,499 $ 229,515 $ (41,327) $ 188,188 (1) North America depreciation and amortization expense in the six months ended July 1, 2023 includes accelerated depreciation of $9.1 million from reviews of equipment capacity optimization. To conform with current period presentation, certain amounts in prior period information have been reclassified. Reconciliations of income from continuing operations, net of tax to Adjusted EBITDA from continuing operations are as follows: Three Months Ended Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 (Loss) income from continuing operations, net of tax $ (18,491) $ 22,502 (46,221) 30,967 Income tax expense 9,563 10,751 6,132 14,239 Depreciation and amortization (1) 28,249 38,214 69,678 66,557 Interest expense, net 16,564 20,854 32,256 42,346 Special items: Net legal and professional expenses and settlements (2) 20,346 4,386 37,536 6,208 Restructuring and asset-related charges (3)(4) 16,447 6,812 34,506 16,078 M&A related costs (5) 5,053 1,269 6,178 3,969 Net loss (gain) on sale of property and equipment (6) 110 168 (2,755) 87 Loss on extinguishment and refinancing of debt (7) — — 1,449 — Share-based compensation expense (8) 5,074 4,749 10,133 8,873 Non-cash foreign exchange transaction/translation (gain) loss (9) (1,192) 447 (2,738) (1,168) Other special items (10) 3,116 (1,281) 7,393 32 Adjusted EBITDA from continuing operations $ 84,839 $ 108,871 $ 153,547 $ 188,188 (1) Depreciation and amortization expense in the six months ended June 29, 2024 includes accelerated amortization of $14.1 million in Corporate and unallocated costs for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. Depreciation and amortization expense in the three and six months ended July 1, 2023 includes accelerated depreciation of $9.1 million in North America from reviews of equipment capacity optimization. (2) Net legal and professional expenses and settlements include non-recurring transformation journey expenses of $18.2 million and $34.6 million in the three and six months ended June 29, 2024, respectively, and $3.5 million and $4.9 million in the three and six months ended July 1, 2023, respectively. These expenses primarily relate to the engagement of one transformation consultant for a period spanning third quarter of 2023 through the fourth quarter of 2024, for which we incurred $13.8 million and $28.4 million in the three and six months ended June 29, 2024, respectively, and $0.4 million in the three and six months ended July 1, 2023. Additionally, net legal and professional expenses and settlements include amounts relating to litigation of historic legal matters of $1.5 million and $2.6 million in the three and six months ended June 29, 2024, respectively, and of $1.1 million and $1.4 million and in the three and six months ended July 1, 2023, respectively. (3) Represents severance, accelerated depreciation and amortization, equipment relocation and other expenses directly incurred as a result of restructuring events. The restructuring charges primarily relate to charges incurred to change the operating structure, eliminate certain roles, and close certain manufacturing facilities in our North America and Europe segments. (4) For the three and six months ended June 29, 2024, $6.4 million of product and inventory-related charges related to announced facility closures were detrimental to Adjusted EBITDA. (5) M&A related costs consists primarily of legal and professional expenses related to the potential disposition of Towanda. (6) Net gain on sale of property and equipment, primarily in Chile, in the six months ended June 29, 2024. (7) Loss on extinguishment and refinancing of debt of $1.4 million associated with an amendment of our Term Loan Facility. (8) Represents non-cash equity-based compensation expense related to the issuance of share-based awards. (9) Non-cash foreign exchange transaction/translation gain primarily associated with fair value adjustments of foreign currency derivatives and revaluation of balances denominated in foreign currencies. (10) Other special items not core to ongoing business activity include: (i) in the three months ended June 29, 2024, a one-time realized foreign currency loss of $1.6 million in our Europe segment related to a cash repatriation event; (ii) in the three months ended July 1, 2023, ($2.8) million in compensation and non-income taxes associated with exercises of legacy equity awards in our Europe segment; (iii) in the six months ended June 29, 2024, a loss of $4.3 million of cumulative foreign currency translation adjustments related to the substantial liquidation of a foreign subsidiary in Chile in our North America segment, a one-time realized foreign currency loss of $1.6 million in our Europe segment related to a cash repatriation event, and ($1.5) million of cash received on an impaired note in Corporate and unallocated costs. To conform with current period presentation, certain amounts in prior period information have been reclassified.

Capital Stock

Capital Stock	6 Months Ended
	Jun. 29, 2024
Equity [Abstract]
Capital Stock	Capital Stock Preferred Stock - Our Board of Directors is authorized to issue Preferred Stock from time to time in one or more series and with such rights, privileges, and preferences as the Board of Directors shall from time to time determine. We have not issued any shares of Preferred Stock. Common Stock - Common Stock includes the basis of shares outstanding plus amounts recorded as additional paid-in capital. Shares outstanding exclude the shares issued to the Employee Benefit Trust that are considered similar to treasury shares and total 193,941 shares at both June 29, 2024 and December 31, 2023 with a total original issuance value of $12.4 million. We record share repurchases on their trade date and reduce shareholders’ equity and increase accounts payable. Repurchased shares are retired, and the excess of the repurchase price over the par value of the shares is charged to retained earnings. On July 28, 2022, our Board of Directors decreased our previous repurchase authorization of $400.0 million to a total aggregate value of $200.0 million with no expiration date. As of June 29, 2024, $175.7 million was remaining under the repurchase program. During the three and six months ended June 29, 2024, we repurchased 1,600,000 shares of our Common Stock at an average price of $15.18. We did not repurchase shares of our Common Stock during the three and six months ended July 1, 2023.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 29, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The basic and diluted income per share calculations were determined based on the following share data : Three Months Ended Six Months Ended June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 Weighted average outstanding shares of Common Stock basic 85,271,699 84,964,935 85,397,067 84,781,940 Restricted stock units, performance share units and options to purchase Common Stock — 799,850 — 635,404 Weighted average outstanding shares of Common Stock diluted 85,271,699 85,764,785 85,397,067 85,417,344 For the three and six months ended June 29, 2024, we had net losses from operations. As a result, no potentially dilutive securities were included in the denominator for computing diluted loss per share as their inclusion would have been antidilutive. The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income per share as their inclusion would be anti-dilutive: Three Months Ended Six Months Ended June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 Common Stock options 1,265,738 1,755,793 1,243,864 1,714,881 Restricted stock units 1,071,024 6,371 1,181,019 18,197 Performance share units 511,392 317,532 430,981 256,435

Stock Compensation

Stock Compensation	6 Months Ended
	Jun. 29, 2024
Share-Based Payment Arrangement [Abstract]
Stock Compensation	Stock Compensation The activity under our incentive plans for the periods presented are reflected in the following tables: Three Months Ended June 29, 2024 July 1, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted — $ — 26,917 $ 13.15 Options exercised 48,728 $ 9.87 19,715 $ 9.83 Options cancelled 65,331 $ 16.31 70,495 $ 21.30 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 100,177 $ 19.21 154,324 $ 13.70 PSUs granted — $ — 15,209 $ 17.69 Six Months Ended June 29, 2024 July 1, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 365,412 $ 18.52 262,809 $ 13.28 Options exercised 191,908 $ 13.02 19,715 $ 9.83 Options cancelled 74,471 $ 17.67 77,890 $ 21.77 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 936,088 $ 18.60 1,490,329 $ 13.26 PSUs granted 417,347 $ 22.60 307,273 $ 17.38 Stock-based compensation expense w as $5.0 million and $10.1 million for the three and six months ended June 29, 2024 and $4.8 million and $8.9 million for the three and six months ended July 1, 2023, respectively. As of June 29, 2024, we had $26.7 million of total unrecognized compensation expense related to non-vested share-based compensation arrangements. This cost is expected to be recognized over the remaining weighted-average vesting period of 1.69 years.

Restructuring and Asset-Related

Restructuring and Asset-Related Charges	6 Months Ended
	Jun. 29, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Asset-Related Charges	Restructuring and Asset-Related Charges We engage in restructuring activities focused on improving productivity and operating margins. Restructuring costs primarily relate to costs associated with workforce reductions, plant consolidations and closures, and changes to the management structure to align with our operations. Other restructuring associated costs primarily consist of equipment relocation and facility restoration costs. Asset-related charges consist of accelerated depreciation and amortization of assets due to changes in asset useful lives. The following table summarizes the restructuring and asset-related charges for the periods indicated: (amounts in thousands) North Europe Corporate Total Three Months Ended June 29, 2024 Restructuring severance and employee-related charges $ 2,062 $ 3,877 $ 355 $ 6,294 Other restructuring associated costs 2,018 1,861 — 3,879 Asset-related charges 5,147 931 196 6,274 Other restructuring associated costs and asset-related charges 7,165 2,792 196 10,153 Total restructuring and asset-related charges $ 9,227 $ 6,669 $ 551 $ 16,447 Three Months Ended July 1, 2023 Restructuring severance and employee-related charges $ 286 $ 1,706 $ 639 $ 2,631 Other restructuring associated costs (income) 4,306 (1,191) — 3,115 Asset-related charges 1,066 — — 1,066 Other restructuring associated costs and asset-related charges (income) 5,372 (1,191) — 4,181 Total restructuring and asset-related charges, net $ 5,658 $ 515 $ 639 $ 6,812 (amounts in thousands) North Europe Corporate Total Six Months Ended June 29, 2024 Restructuring severance and employee-related charges $ 10,951 $ 7,275 $ 560 $ 18,786 Other restructuring associated costs 4,108 2,419 — 6,527 Asset-related charges 8,066 931 196 9,193 Other restructuring associated costs and asset-related charges 12,174 3,350 196 15,720 Total restructuring and asset-related charges $ 23,125 $ 10,625 $ 756 $ 34,506 Six Months Ended July 1, 2023 Restructuring severance and employee-related charges $ 3,342 $ 2,793 $ 826 $ 6,961 Other restructuring associated costs (income) 6,891 (1,191) — 5,700 Asset-related charges 3,237 180 — 3,417 Other restructuring associated costs and asset-related charges (income) 10,128 (1,011) — 9,117 Total restructuring and asset-related charges $ 13,470 $ 1,782 $ 826 $ 16,078 The following is a summary of the restructuring accruals recorded and charges incurred: (amounts in thousands) June 29, 2024 July 1, 2023 Balance as of January 1 $ 3,375 $ 5,021 Current period charges 25,313 12,661 Payments (15,586) (15,067) Currency translation (206) 75 Balance at period end $ 12,896 $ 2,690 Restructuring accruals are expected to be paid within the next 12 months and are included within accrued expenses and other current liabilities in the consolidated balance sheet. On April 11, 2024, we announced plans to close two manufacturing facilities, located in Vista, California and Hawkins, Wisconsin in a continuing effort to simplify our footprint and drive operational efficiencies. As of June 29, 2024 the remaining restructuring accrual for these plans is $8.6 million and the remaining cash outlay is expected to be $22.4 million. We expect to substantially complete the facility closures by the first quarter of 2025. After completion of the site closures, we expect to realize annual pre-tax income improvements of at least $11.0 million. Costs and cash outlays associated with the plans: North America: Vista, California and Hawkins, Wisconsin Total Estimated Cumulative Costs in the Three Months Ended Costs in the Six Months Ended (amounts in thousands) Costs Costs to-date June 29, 2024 June 29, 2024 Restructuring severance and employee-related charges (1) $ 11,500 $ 10,546 $ 1,726 $ 10,546 Other restructuring associated costs (1) 7,600 1,355 1,355 1,355 Product-related cash charges (2) 5,000 2,649 2,649 2,649 Total cash charges 24,100 14,550 5,730 14,550 Asset-related charges (1) 9,300 3,215 3,215 3,215 Inventory and other product-related non-cash charges (3) 4,400 3,706 3,706 3,706 Total non-cash charges 13,700 6,921 6,921 6,921 Total costs $ 37,800 $ 21,471 $ 12,651 $ 21,471 Total cash outlays $ 28,100 $ 5,679 $ 5,679 $ 5,679 (1) The charges incurred in the three and six months ended June 29, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. (2) The product-related cash charges incurred in the three and six months ended June 29, 2024 were detrimental to Net Sales in the accompanying Consolidated Statement of Operations. (3) The inventory and other product-related non-cash charges in the three and six months ended June 29, 2024 were included in Cost of Sales in the accompanying Consolidated Statement of Operations. During 2023, we announced plans to transform our European operations by changing the operating structure, eliminating certain roles and rationalizing our manufacturing footprint. We plan to close two manufacturing facilities and transfer production to other facilities within Europe. During the second quarter of 2024, we announced additional plans, increasing the total estimated costs by approximately $8.2 million to $27.5 million, after identifying additional opportunities to optimize our European operating structure. As of June 29, 2024 the remaining restructuring accrual for these plans is $3.2 million and the remaining cash outlay is expected to be $15.8 million. We expect to substantially complete these initiatives by the end of 2024. Costs and cash outlays associated with the plans: Europe Total Estimated Cumulative Costs in the Three Months Ended Costs in the Six Months Ended (amounts in thousands) Costs Costs to-date June 29, 2024 June 29, 2024 Restructuring severance and employee-related charges (1) $ 19,200 $ 10,289 $ 3,825 $ 7,207 Other restructuring associated costs (1) 4,400 2,740 1,830 2,316 Total cash charges 23,600 13,029 5,655 9,523 Asset-related non-cash charges (1) 600 573 573 573 Capital expenditures 3,300 1,264 — 1,264 Total costs $ 27,500 $ 14,866 $ 6,228 $ 11,360 Total cash outlays $ 26,900 $ 11,058 $ 4,864 $ 8,943 (1) The charges incurred in the three and six months ended June 29, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. In the third quarter of 2023, we announced plans to close two manufacturing facilities, located in Tijuana, Mexico and Vista, California as part of our footprint rationalization activities. As of June 29, 2024, the remaining restructuring accrual for these plans is $0.8 million and the remaining cash outlay is expected to be $1.4 million. We expect to substantially complete the facility closures by the end of 2024. Costs and cash outlays associated with the plans: North America: Tijuana, Mexico and Vista, California Total Estimated Cumulative Costs in the Three Months Ended Costs in the Six Months Ended (amounts in thousands) Costs Costs to-date June 29, 2024 June 29, 2024 Restructuring severance and employee-related charges (1) $ 7,900 $ 7,502 $ 13 $ (311) Other restructuring associated costs (1) 2,700 2,545 322 1,944 Total cash charges 10,600 10,047 335 1,633 Asset-related charges (1) 6,600 6,628 — 2,919 Inventory and other product-related non-cash charges (2) 1,500 1,466 — — Total non-cash charges 8,100 8,094 — 2,919 Total costs $ 18,700 $ 18,141 $ 335 $ 4,552 Total cash outlays $ 10,600 $ 9,187 $ 471 $ 2,560 (1) The related charges incurred in the three and six months ended June 29, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. (2) The inventory and other product-related non-cash charges incurred during 2023 were included in Cost of Sales in the Consolidated Statement of Operations. In the first quarter of 2023, we announced to employees a restructuring plan to close a manufacturing facility in Atlanta, Georgia. We completed the plant closure during 2023, with total pre-tax restructuring expenses and other closure costs of approximately $17.7 million, including $1.1 million of capital expenditures, and total cash outlays of approximately $12.9 million. The primary expenses incurred were accelerated depreciation and amortization, equipment relocation costs, and restructuring severance and employee-related charges.

Held for Sale

Held for Sale	6 Months Ended
	Jun. 29, 2024
Discontinued Operations and Disposal Groups [Abstract]
Held for Sale	Discontinued Operations On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell our Australasia business (“JW Australia”), for a purchase price of approximately AUD $688 million. On July 2, 2023, we completed the sale, receiving net cash proceeds of approximately $446 million, including $3.3 million of cash received from the settlement of certain forward contracts. We have classified the results of operations for the JW Australia reportable segment, together with certain costs related to the sale, as discontinued operations within the consolidated statements of operations for all periods presented. Subsequent to the completion of the sale, we entered into an agreement to provide certain transition services to JW Australia, including providing information technology post-closing services, purchases under a supply agreement, and reimbursement for certain costs to upgrade specific IT systems up to a capped amount. As of June 29, 2024, we had a liability of $4.5 million relating to these matters, which was included in accrued expenses and other current liabilities in our consolidated balance sheet. As of December 31, 2023, our liability relating to these matters was $8.2 million, of which $6.1 million was included in accrued expenses and other current liabilities, and the remaining was included in deferred credits and other liabilities in the accompanying consolidated balance sheet. Components of amounts reflected in the consolidated statements of operations related to discontinued operations are presented in the table, as follows: Three Months Ended Six Months Ended (amounts in thousands) July 1, 2023 July 1, 2023 Net revenues $ 156,206 $ 301,876 Cost of sales 106,186 211,575 Gross margin 50,020 90,301 Selling, general and administrative 28,732 61,477 Restructuring and asset-related charges — — Operating income 21,288 28,824 Interest income, net (414) (685) Other income, net (871) (2,257) Income from discontinued operations before taxes 22,573 31,766 Income tax expense 6,794 9,318 Income from discontinued operations, net of tax $ 15,779 $ 22,448 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows through the divestiture date of July 2, 2023. The following table presents cash flow and non-cash information related to discontinued operations: Six Months Ended (amounts in thousands) July 1, 2023 Depreciation and amortization $ 5,196 Capital expenditures 6,229 Share-based incentive compensation 812 Provision for bad debt 5,062 As of June 29, 2024 and December 31, 2023, the assets and liabilities associated with the court-ordered divestiture of the Company’s Towanda, PA operations (“Towanda”) as described further in Note 21 - C ommitments and Contingencies, qualify as held for sale. Since the Company will continue manufacturing door skins for its internal needs, the divestiture decision did not represent a strategic shift thereby precluding the divestiture as qualifying as a discontinued operation. In addition to the Towanda net assets, we own assets in St. Kitts and Mexico, which are also classified as held for sale in the accompanying consolidated balance sheet as of June 29, 2024. St. Kitts and Mexico collectively had assets held for sale of $4.8 million and liabilities held for sale of $0.2 million at June 29, 2024. As of December 31, 2023, the assets and liabilities classified as held for sale are those of Towanda. As of June 29, 2024 and December 31, 2023, the related assets and liabilities included within the summary below were expected to be disposed of within the next twelve months and are included in assets held for sale and liabilities held for sale in the accompanying consolidated balance sheets. (amounts in thousands) June 29, 2024 December 31, 2023 Assets Accounts receivable, net $ 42 $ — Inventories $ 20,133 $ 17,337 Other current assets 150 108 Property and equipment, net 57,965 50,672 Intangible assets, net 1,471 1,471 Goodwill 65,000 65,000 Operating lease assets, net 975 975 Assets held for sale $ 145,736 $ 135,563 Liabilities Accounts payable $ 65 $ — Accrued payroll and benefits $ 1,239 $ 901 Accrued expenses and other current liabilities 6,610 6,126 Operating lease liability 17 37 Liabilities held for sale $ 7,931 $ 7,064

Other (Income) Expense, Net

Other (Income) Expense, Net	6 Months Ended
	Jun. 29, 2024
Other Income and Expenses [Abstract]
Other (Income) Expense, Net	Other (Income) Expense, Net The table below summarizes the amounts included in other income, net in the accompanying consolidated statements of operations: Three Months Ended Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 JW Australia Transition Services Agreement cost recovery $ (2,402) $ — $ (6,542) $ — Foreign currency losses (gains), net 632 (231) (835) (2,102) Pension expense 513 1,657 1,028 3,351 Cash received on investment in real estate (379) — (2,527) — Recovery of cost from receipts on impaired notes — (281) (1,389) (1,675) Governmental assistance (270) (44) (927) (191) Income from refund of deposits for China antidumping and countervailing duties (1) — — (2,947) — Insurance reimbursement — — (1,655) (1,234) Other items, net (582) 1,058 (957) 323 Total other income, net $ (2,488) $ 2,159 $ (16,751) $ (1,528) (1) Represents the refund of deposits for antidumping and countervailing duties on wood mouldings and millwork products purchased from China from 2020 to 2022.

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Foreign currency derivatives – As a multinational corporation, we are exposed to the impact of foreign currency fluctuations. To the extent borrowings, sales, purchases, or other transactions are not executed in the local currency of the operating unit, we are exposed to foreign currency risk. In most of the countries in which we operate, the exposure to foreign currency movements is limited because the operating revenues and expenses of our business units are substantially denominated in the local currency. To mitigate the exposure, we may enter into a variety of foreign currency derivative contracts. To manage the effect of exchange fluctuations on forecasted sales, purchases, acquisitions, capital expenditures, and certain intercompany transactions that are denominated in foreign currencies, we have foreign currency derivative contracts with a total notional amount of $70.9 million as of June 29, 2024. We have foreign currency derivative contracts, with a total notional amount of $83.9 million, to manage the risks of foreign currency gains and losses on intercompany loans and interest. We do not use derivative financial instruments for trading or speculative purposes. With the exception of the AUD/USD forward contracts entered into on April 18, 2023 described below, as of June 29, 2024, we have not elected hedge accounting for any foreign currency derivative contracts. We record mark-to-market changes in the values of these derivatives in other income, net. We recorded mark-to-market losses of $0.2 million and gains of $1.5 million relating to foreign currency derivatives in the three and six months ended June 29, 2024, respectively. We recorded mark-to-market losses of $0.9 million and mark-to-market gains of $0.1 million in the three and six months ended July 1, 2023, respectively. On April 18, 2023 we entered into forward contracts to sell a total of AUD 420.0 million and receive USD at exchange rates ranging from 0.6751 USD to 0.6759 USD to 1.0 AUD to mitigate the impact of the Australian dollar currency fluctuations on our net investment in JELD-WEN Australia Pty. Ltd. We designated the forward contracts as net investment hedges. No portion of these contracts were deemed ineffective during the three months ended July 1, 2023. The contracts matured during the three months ended September 30, 2023 and the gain, net of forward points, was included in the gain on the sale of JW Australia. Interest rate derivatives – We are exposed to interest rate risk in connection with our variable rate long-term debt. In May 2020, we entered into interest rate swap agreements with notional amounts aggregating to $370.0 million to manage this risk. The interest rate swap agreements matured in December 2023. Initially, the agreements had a weighted average fixed rate of 0.395% swapped against one-month USD LIBOR floored at 0.00%. In June 2023, we amended the agreements to replace LIBOR with a Term SOFR based rate. The amended agreements had a weighted average fixed rate of 0.317% swapped against one-month USD-SOFR CME Term floored at (0.10)%. All other terms and conditions were unchanged. We designated the interest rate swap agreements as cash flow hedges and they effectively fixed the interest rate on a corresponding portion of the aggregate debt outstanding under our Term Loan Facility. In February 2024, we entered into interest rate collar agreements with a cap rate of 4.50% paid against one-month USD-SOFR CME Term floored at 3.982% and 3.895% with outstanding notional amounts aggregating to $100.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. The interest rate collar agreements were designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and mature in February 2026. No portion of these interest rate contracts were deemed ineffective during the three and six months ended June 29, 2024. In other comprehensive income, we recorded pre-tax mark-to-market gains pre-tax mark-to-market gains As of June 29, 2024, approximately $0.4 million in gains is expected to be reclassified to interest income over the next 12 months. Other derivative instruments – From time to time, we enter into other types of derivative instruments immaterial to the consolidated financial statements. Unless otherwise disclosed, these instruments are not designated as hedging instruments and mark-to-market adjustments are recorded in the statement of operations each period. The fair values of derivative instruments held are as follows: Derivative assets (amounts in thousands) Balance Sheet Location June 29, 2024 December 31, 2023 Derivatives designated as hedging instruments: Interest rate contracts Other current assets $ 473 $ — Derivatives not designated as hedging instruments: Foreign currency forward contracts Other current assets $ 491 $ 1,186 Other derivative instruments Other current assets $ 63 $ 38 Derivative liabilities (amounts in thousands) Balance Sheet Location June 29, 2024 December 31, 2023 Derivatives designated as hedging instruments: Interest rate contracts Deferred credits and other liabilities $ 37 $ — Derivatives not designated as hedging instruments: Foreign currency forward contracts Accrued expenses and other current liabilities $ 733 $ 2,975 Other derivative instruments Accrued expenses and other current liabilities $ — 21

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 29, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments We record financial assets and liabilities at fair value based on FASB guidance related to fair value measurements. The guidance requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Three levels of inputs may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Quoted market-based inputs or unobservable inputs that are corroborated by market data. Level 3 – Unobservable inputs that are not corroborated by market data. The recorded carrying amounts and fair values of these instruments were as follows: June 29, 2024 (amounts in thousands) Carrying Amount Total Level 1 Level 2 Level 3 Assets: Cash equivalents $ 158,953 $ 158,953 $ 158,953 $ — $ — Derivative assets, recorded in other current assets 1,027 1,027 — 1,027 — Deferred compensation plan assets, recorded in other assets 4,485 4,485 — 4,485 — Liabilities: Debt, recorded in long-term debt and current maturities of long-term debt $ 1,219,521 $ 1,196,522 $ — $ 1,196,522 $ — Derivative liabilities, recorded in accrued expenses and other current liabilities 733 733 — 733 — Derivative liabilities, recorded in deferred credits and other liabilities 37 37 — 37 — December 31, 2023 (amounts in thousands) Carrying Amount Total Level 1 Level 2 Level 3 Assets: Cash equivalents $ 71,139 $ 71,139 $ 71,139 $ — $ — Derivative assets, recorded in other current assets 1,224 1,224 — 1,224 — Deferred compensation plan assets, recorded in other assets 2,098 2,098 — 2,098 — Liabilities: Debt, recorded in long-term debt and current maturities of long-term debt $ 1,232,780 $ 1,209,961 $ — $ 1,209,961 $ — Derivative liabilities, recorded in accrued expenses and other current assets 2,996 2,996 — 2,996 — Derivative assets and liabilities reported in level 2 primarily include: (1) as of June 29, 2024, foreign currency derivative contracts and interest rate collar agreements; (2) as of December 31, 2023, foreign currency derivative contracts. See Note 19 - Derivative Financial Instruments for additional information about our derivative assets and liabilities. Deferred compensation plan assets reported in level 2 consist of mutual funds. There are no material non-financial assets or liabilities as of June 29, 2024 or December 31, 2023.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation – We are involved in various legal proceedings, claims, and government audits arising in the ordinary course of business. We record our best estimate of a loss when the loss is considered probable and the amount of such loss can be reasonably estimated. When a loss is probable and there is a range of estimated loss with no best estimate within the range, we record the minimum estimated liability related to the lawsuit or claim. As additional information becomes available, we reassess the potential liability and revise our accruals, if necessary. Because of uncertainties related to the resolution of lawsuits and claims, the ultimate outcome may differ materially from our estimates. Other than the matters described below, there were no proceedings or litigation matters involving the Company or its property as of June 29, 2024 that we believe would have a material adverse effect on our consolidated financial position or cash flows, although they could have a material adverse effect on our operating results for a particular reporting period. Steves & Sons, Inc. v JELD-WEN, Inc. – We sell molded door skins to certain customers pursuant to long-term contracts, and these customers in turn use the molded door skins to manufacture interior doors and compete directly against us in the marketplace. We gave notice of termination of one of these contracts and, on June 29, 2016, the counterparty to the agreement, Steves & Sons, Inc. (“Steves”) filed a claim against JWI in the U.S. District Court for the Eastern District of Virginia, Richmond Division (the “Eastern District of Virginia”). The complaint alleged that our acquisition of CMI, a competitor in the molded door skins market, together with subsequent price increases and other alleged acts and omissions, violated antitrust laws, and constituted a breach of contract and breach of warranty. Specifically, the complaint alleged that our acquisition of CMI substantially lessened competition in the molded door skins market. The complaint sought declaratory relief, ordinary and treble damages, and injunctive relief, including divestiture of certain assets acquired in the CMI acquisition. In February 2018, a jury in the Eastern District of Virginia returned a verdict that was unfavorable to JWI with respect to Steves’ claims that our acquisition of CMI violated Section 7 of the Clayton Act, and found that JWI breached the supply agreement between the parties (the “Original Action”). The verdict awarded Steves $12.2 million for past damages under both the Clayton Act and breach of contract claims and $46.5 million in future lost profits under the Clayton Act claim. During the course of the proceedings in the Eastern District of Virginia, we discovered certain facts that led us to conclude that Steves, its principals, and certain former employees of the Company had misappropriated Company trade secrets, violated the terms of various agreements between the Company and those parties, and violated other laws. On May 11, 2018, a jury in the Eastern District of Virginia returned a verdict on our trade secrets claims against Steves and awarded damages in the amount of $1.2 million. The presiding judge entered a judgment in our favor for those damages, and the entire amount has been paid by Steves. On August 16, 2019, the presiding judge granted Steves’ request for an injunction, prohibiting us from pursuing certain claims against individual defendants pending in Bexar County, Texas (the “Steves Texas Trade Secret Theft Action”). On September 11, 2019, JELD-WEN filed a notice of appeal of the Eastern District of Virginia’s injunction to the Fourth Circuit Court of Appeals (the “Fourth Circuit”). On March 13, 2019, the presiding judge entered an Amended Final Judgment Order in the Original Action, awarding $36.5 million in past damages under the Clayton Act (representing a trebling of the jury’s verdict) and granted divestiture of certain assets acquired in the CMI acquisition, subject to appeal. The judgment also conditionally awarded damages in the event the judgment was overturned on appeal. Specifically, the court awarded $139.4 million as future antitrust damages in the event the divestiture order was overturned on appeal and $9.9 million as past contract damages in the event both the divestiture and antitrust claims were overturned on appeal. On April 12, 2019, Steves filed a petition requesting an award of its fees and a bill of costs, seeking $28.4 million in attorneys’ fees and $1.7 million in costs in connection with the Original Action. On November 19, 2019, the presiding judge entered an order for further relief awarding Steves an additional $7.1 million in damages for pricing differences from the date of the underlying jury verdict through May 31, 2019 (the “Pricing Action”). We also appealed that ruling. On April 14, 2020, Steves filed a motion for further supplemental relief for pricing differences from the date of the prior order and going forward through the end of the parties’ current supply agreement (the “Future Pricing Action”). We opposed that request for further relief. JELD-WEN filed a supersedeas bond and notice of appeal of the judgment, which was heard by the Fourth Circuit on May 29, 2020. On February 18, 2021, the Fourth Circuit issued its decision on appeal in the Original Action, affirming the Amended Final Judgment Order in part and vacating and remanding in part. The Fourth Circuit vacated the Eastern District of Virginia’s alternative $139.4 million lost-profits award, holding that award was premature because Steves has not suffered the purported injury on which its claim for future lost profits rests. The Fourth Circuit also vacated the Eastern District of Virginia’s judgment for Sam Steves, Edward Steves, and John Pierce on JELD-WEN’s trade secrets claims. The Fourth Circuit affirmed the Eastern District of Virginia’s finding of antitrust injury and its award of $36.5 million in past antitrust damages. It also affirmed the Eastern District of Virginia’s divestiture order, while clarifying that JELD-WEN retains the right to challenge the terms of any divestiture, including whether a sale to any particular buyer will serve the public interest, and made clear that the Eastern District of Virginia may need to revisit its divestiture order if the special master who has been appointed by the presiding judge cannot locate a satisfactory buyer. JELD-WEN then filed a motion for rehearing en banc with the Fourth Circuit that was denied on March 22, 2021. On May 1, 2024, JWI filed a motion to modify the Amended Final Judgment (the “Motion”) with the Eastern District of Virginia to vacate all court orders requiring divestiture of the Company’s Towanda operations and certain related assets. In light of changed industry and market factors and conditions, the Company believes that the divestiture of Towanda is no longer warranted and is asking the court for relief from that ruling. The divestiture process is ongoing while the court is reviewing the Motion, and the special master is continuing to oversee the process which includes multiple proposals with varying structures. We made estimates related to the divestiture in the preparation of our financial statements; however, there can be no assurance that the Motion will be granted and that the divestiture requirement will be vacated. There can also be no guarantee that the divestiture will be consummated if the divestiture requirement is not ultimately vacated. During the pendency of the Original Action, on February 14, 2020, Steves filed a complaint and motion for preliminary injunction in the Eastern District of Virginia alleging that we breached the long-term supply agreement between the parties, including, among other claims, by incorrectly calculating the allocation of door skins owed to Steves (the “Allocation Action”). Steves sought an additional allotment of door skins and damages for violation of antitrust laws, tortious interference, and breach of contract. On April 10, 2020, the presiding judge granted Steves’ motion for preliminary injunction, and the parties settled the issues underlying the preliminary injunction on April 30, 2020 and the Company reserved the right to appeal the ruling in the Fourth Circuit. The Company believed all the claims lacked merit and moved to dismiss the antitrust and tortious interference claims. On June 2, 2020, we entered into a settlement agreement with Steves to resolve the Pricing Action, the Future Pricing Action, and the Allocation Action. As a result of the settlement, Steves filed a notice of satisfaction of judgment in the Pricing Action, withdrew its Future Pricing Action with prejudice, and filed a stipulated dismissal with prejudice in the Allocation Action. The Company also withdrew its appeal of the Pricing Action. The parties agreed to bear their own respective attorneys’ fees and costs in these actions. In partial consideration of the settlement, JWI and Steves entered into an amended supply agreement satisfactory to both parties that, by its terms, ended on September 10, 2021. This settlement had no effect on the Original Action between the parties except to agree that certain specific terms of the Amended Final Judgment Order in the Original Action would apply to the amended supply agreement during the pendency of the appeal of the Original Action. On April 2, 2021, JWI and Steves filed a stipulation regarding the amended supply agreement in the Original Action, stating that regardless of whether the case remains on appeal as of September 10, 2021, and absent further order of the court, the amended supply agreement would be extended until the divestiture of Towanda and certain related assets is complete and Steves’ new supply agreement with the company that acquires Towanda is in effect. We continue to believe the claims in the settled actions lacked merit and made no admission of liability in these matters. On October 7, 2021, we entered into a settlement agreement with Steves to resolve the following: (i) Steves’ past and any future claims for attorneys’ fees, expenses, and costs in connection with the Original Action, except that Steves and JWI each reserved the right to seek attorneys’ fees arising out of any challenge of the divestiture process or the final divestiture order; (ii) the Steves Texas Trade Secret Theft Action and the related Fourth Circuit appeal of the Eastern District of Virginia’s injunction in the Original Action; (iii) the past damages award in the Original Action; and (iv) any and all claims and counterclaims, known or unknown, that were asserted or could have been asserted against each other from the beginning of time through the date of the settlement agreement. As a result of the settlement, the parties filed a stipulated notice of satisfaction of the past antitrust damages judgment and a stipulated notice of settlement of Steves’ claim for attorneys’ fees, expenses, and costs against JWI in the Original Action, and Steves filed a notice of withdrawal of its motion for attorneys’ fees and expenses and bill of costs in the Original Action. The Company also filed a notice of dismissal with prejudice and agreed to take no judgment in the Steves Texas Trade Secret Theft Action, and the parties filed a joint agreement for dismissal of the injunction appeal in the Fourth Circuit. On November 3, 2021, we paid $66.4 million to Steves under the settlement agreement. In re JELD-WEN Holding, Inc. Derivative Litigation – On February 2, 2021, Jason Aldridge, on behalf of the Company, filed a derivative action in the U.S. District Court for the District of Delaware against certain current and former executives and directors of the Company, alleging that the individual defendants breached their fiduciary duties by allowing the wrongful acts alleged in the Steves and Cambridge actions, as well as violations of Section 14(a) and 20(a) of the Exchange Act, unjust enrichment, and waste of corporate assets among other allegations (the “Aldridge Action”). The lawsuit sought compensatory damages, equitable relief, and an award of attorneys’ fees and costs. The plaintiff filed an amended complaint on May 10, 2021. On June 21, 2021, prior to a response from the Company in the Aldridge Action, Shieta Black and the Board of Trustees of the City of Miami General Employees’ & Sanitation Employees’ Retirement Trust, on behalf of the Company, filed a derivative action in the U.S. District Court for the District of Delaware against certain current and former executives and directors of the Company and Onex Corporation (“Onex”), alleging that the defendants breached their fiduciary duties by allowing the wrongful acts alleged in the Steves and Cambridge actions, as well as insider trading, and unjust enrichment among other allegations (the “Black Action”). The lawsuit sought compensatory damages, corporate governance reforms, restitution, equitable relief, and an award of attorneys’ fees and costs. The court granted the Black and Aldridge plaintiffs in motion to consolidate the lawsuits on July 16, 2021. On June 20, 2022, the parties entered into a settlement agreement of the consolidated matters, which was approved by the Court on approval of the December 20, 2022, and the cases were dismissed with prejudice. In January 2023, the Company, as putative plaintiff, received approximately $10.5 million after attorneys’ fees and costs were deducted as part of the settlement. Canadian Antitrust Litigation – On May 15, 2020, Développement Émeraude Inc., on behalf of itself and others similarly situated, filed a putative class action lawsuit against the Company and Masonite in the Superior Court of the Province of Quebec, Canada, which was served on us on September 18, 2020 (“the Quebec Action”). The putative class consists of any person in Canada who, since October 2012, purchased one or more interior molded doors from the Company or Masonite. The suit alleges an illegal conspiracy between the Company and Masonite to agree on prices, the distribution of market shares and/or the production levels of interior molded doors and that the plaintiffs suffered damages in that they were charged and paid higher prices for interior molded doors than they would have had to pay but for the alleged anti-competitive conduct. The plaintiffs are seeking compensatory and punitive damages, attorneys’ fees and costs. On September 9, 2020, Kate O’Leary Swinkels, on behalf of herself and others similarly situated, filed a putative class action against the Company and Masonite in the Federal Court of Canada, which was served on us on September 29, 2020 (the “Federal Court Action”). The Federal Court Action makes substantially similar allegations to the Quebec Action and the putative class is represented by the same counsel. In February 2021, the plaintiff in the Federal Court Action issued a proposed Amended Statement of Claim that replaced the named plaintiff, Kate O’Leary Swinkels, with David Regan. The plaintiff has sought a stay of the Quebec Action while the Federal Court Action proceeds. On July 14, 2023, the Company entered into an agreement in principle with class counsel to resolve both actions for an immaterial amount, which the Company recorded in the second quarter of 2023. The proposed settlement remains subject to formal settlement documentation and court approval. The Company continues to believe the plaintiffs’ claims lack merit and denies any liability or wrongdoing for the claims made against the Company. We have evaluated the claims against us and recorded provisions based on management’s judgment about the probable outcome of the litigation and have included our estimates in accrued expenses in the accompanying balance sheets. See Note 8 - Accrued Expenses and Other Current Liabilities . While we expect a favorable resolution to these matters, the dispute resolution process could be lengthy, and if the plaintiffs were to prevail completely or substantially in the respective matters described above, such an outcome could have a material adverse effect on our operating results, consolidated financial position, or cash flows. Self-Insured Risk – We self-insure substantially all of our domestic business liability risks including general liability, product liability, warranty, personal injury, auto liability, workers’ compensation, and employee medical benefits. Excess insurance policies from independent insurance companies generally cover exposures between $5.0 million and $200.0 million for domestic product liability risk and exposures between $3.0 million and $200.0 million for auto, general liability, personal injury, and workers’ compensation. We estimate our provision for self-insured losses based upon an evaluation of current claim exposure and historical loss experience. Actual self-insurance losses may vary significantly from these estimates. At June 29, 2024 and December 31, 2023, our accrued liability for self-insured risks was $88.8 million and $89.2 million, respectively. Indemnifications – At June 29, 2024, we had commitments related to certain representations made in contracts for sale of businesses or property, including the divestiture of JW Australia. Our indemnity obligations under the relevant agreements may be limited in terms of time, amount or scope. These representations primarily relate to past actions such as responsibility for transfer taxes if they should be claimed, and the adequacy of recorded liabilities, warranty matters, employment benefit plans, income tax matters, or environmental exposures. As it relates to certain income tax related liabilities, the relevant agreements may not provide any cap for such liabilities, and the period in which we would be liable would lapse upon expiration of the statute of limitation for assessment of the underlying taxes. Because of the conditional nature of these obligations and the unique facts and circumstances involved in each particular agreement, we are unable to reasonably estimate the potential maximum exposure associated with these items. We are not aware of any material amounts claimed or expected to be claimed under these indemnities. From time to time and in limited geographic areas, we have entered into agreements for the sale of our products to certain customers that provide additional indemnifications for liabilities arising from construction or product defects. We cannot estimate the potential magnitude of such exposures, but to the extent specific liabilities have been identified related to product sales, liabilities have been provided in the warranty accrual in the accompanying consolidated balance sheets. Other Financing Arrangements – At times we are required to provide letters of credit, surety bonds, or guarantees to meet various performance, legal, warranty, environmental, workers compensation, licensing, utility, and governmental requirements. Stand-by letters of credit are provided to certain customers and counterparties in the ordinary course of business as credit support for contractual performance guarantees, advanced payments received from customers, and future funding commitments. The stated values of these letters of credit agreements, surety bonds, and guarantees were $72.2 million at June 29, 2024 and $68.7 million at December 31, 2023, respectively. Environmental Contingencies – We periodically incur environmental liabilities associated with remediating our current and former manufacturing sites as well as penalties for not complying with environmental rules and regulations. We record a liability for remediation costs when it is probable that we will be responsible for such costs and the costs can be reasonably estimated. These environmental liabilities are estimated based on current available facts and current laws and regulations. Accordingly, it is likely that adjustments to the estimated liabilities will be necessary as additional information becomes available. Short-term environmental liabilities and settlements are recorded in accrued expenses and other current liabilities deferred credits and other liabilities Everett, Washington WADOE Action – In 2007, we were identified by the WADOE as a PLP with respect to our former manufacturing site in Everett, Washington. In 2008, we entered into an Agreed Order with the WADOE to assess historic environmental contamination and remediation feasibility at the site. As part of the order, we agreed to develop a CAP, arising from the feasibility assessment. In December 2020, we submitted to the WADOE a draft feasibility assessment with an array of remedial alternatives, which we considered substantially complete. During 2021, several comment rounds were completed as well as the identification of the Port of Everett and W&W Everett Investment LLC as additional PLPs, with respect to this matter with each PLP being jointly and severally liable for the cleanup costs. The WADOE received the final feasibility assessment on December 31, 2021, containing various remedial alternatives with its preferred remedial alternatives totaling $23.4 million. Based on this study, we have determined our range of possible outcomes to be $11.8 million to $33.4 million. On March 1, 2022, we delivered a draft CAP consistent with the preferred alternatives which was approved by WADOE in August 2023. The existing Agreed Order of 2008 was also modified with WADOE in July 2023 to support the development of the associated CAP investigation, sampling and design components. We have made provisions within our financial statements within the range of possible outcomes; however, the contents and cost of the final CAP and allocation of the responsibility between the identified PLPs could vary materially from our estimates. Towanda, Pennsylvania Consent Order – In December 2020, we entered into a COA with the PaDEP to remove a pile of wood fiber waste from our site in Towanda, Pennsylvania, which we acquired in connection with our acquisition of CMI in 2012, by using it as fuel for a boiler at that site. The COA replaced a 2018 Consent Decree between the Company and PaDEP. Under the COA, we are required to achieve certain periodic removal objectives and ultimately remove the entire pile by August 31, 2025. As of March 30, 2024 and December, 31, 2023 there was $1.4 million, respectively in bonds posted in connection with these obligations. If we are unable to remove this pile by August 31, 2025, then the bonds will be forfeited, and we may be subject to penalties by PaDEP. We currently anticipate meeting all applicable removal deadlines; however, if our operations should change, additional alternatives would be evaluated to meet the prescribed removal timeline.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	6 Months Ended
	Jun. 29, 2024
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 Cash Operating Activities: Operating leases $ 24,622 $ 29,970 Interest payments on financing lease obligations 225 106 Cash paid for amounts included in the measurement of lease liabilities $ 24,847 $ 30,076 Cash Investing Activities: Purchases of securities for deferred compensation plan $ (2,817) $ (770) Sale of securities for deferred compensation plan — 111 Change in securities for deferred compensation plan $ (2,817) $ (659) Cash received on notes receivable 2 — Change in notes receivable $ 2 $ — Non-cash Investing Activities: Property, equipment, and intangibles purchased in accounts payable $ 12,698 $ 5,591 Property, equipment, and intangibles purchased with debt 3,518 7,405 Customer accounts receivable converted to notes receivable 10 96 Cash Financing Activities: Borrowings on long-term debt $ 1,225 $ 126,933 Payments of long-term debt (16,803) (197,259) Payments of debt issuance and extinguishment costs, including underwriting fees (198) — Change in long-term debt and payments of debt extinguishment costs $ (15,776) $ (70,326) Cash paid for amounts included in the measurement of finance lease liabilities $ 1,195 $ 985 Non-cash Financing Activities: Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities $ — $ 732 Accounts payable converted to installment notes 5 176 Other Supplemental Cash Flow Information: Cash taxes paid, net of refunds $ 17,332 $ 25,839 Cash interest paid 39,520 41,859

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Pay vs Performance Disclosure
Net (loss) income	$ (18,491)	$ 38,281	$ (46,221)	$ 53,415

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 29, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Description of Company and Su_2

Description of Company and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 29, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation – The accompanying unaudited consolidated financial statements as of June 29, 2024 and for the three and six months ended June 29, 2024 and July 1, 2023, respectively, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three and six months ended June 29, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or any other period. The accompanying consolidated balance sheet as of December 31, 2023 was derived from audited financial statements included in our Annual Report on Form 10-K. The accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023. On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell our Australasia business (“JW Australia”). On July 2, 2023, we completed the sale. The net assets and operations of the disposal group met the criteria to be classified as “discontinued operations” and are reported as such in all periods presented unless otherwise noted. The consolidated statements of cash flows include cash flows from discontinued operations through the divestiture date of July 2, 2023. See Note 2 - Discontinued Operations for further information. All U.S. dollar and other currency amounts, except per share amounts, are presented in thousands unless otherwise noted.
Fiscal Year	Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more or fewer days included than a traditional 91-day fiscal quarter.
Use of Estimates	Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation, and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in the nature of these estimates.
Recent Accounting Standards Not Yet Adopted	Recent Accounting Standards Not Yet Adopted – In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures . ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the CODM and included within the segment measure of profit or loss, an amount and description of its composition for other segment items to reconcile to segment profit or loss, and the title and position of the entity’s CODM. ASU 2023-07 will be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023, and interim reporting periods in fiscal years beginning after December 31, 2024. We do not expect the guidance to have an impact on our financial positions and results of operations. We are currently evaluating the impact of this guidance on the Company’s disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . ASU 2023-09 expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted, and should be applied either prospectively or retrospectively. We have not elected to early adopt this standard. We do not expect the guidance to have an impact on our financial positions and results of operations. We are currently evaluating the impact of this guidance on the Company’s disclosures. We have considered the applicability and impact of all ASUs. We have assessed ASUs not listed above and have determined that they were either not applicable or were not expected to have a material impact on our financial statements.

Discontinued Operations (Tables

Discontinued Operations (Tables)	6 Months Ended
	Jun. 29, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Discontinued Operations	Components of amounts reflected in the consolidated statements of operations related to discontinued operations are presented in the table, as follows: Three Months Ended Six Months Ended (amounts in thousands) July 1, 2023 July 1, 2023 Net revenues $ 156,206 $ 301,876 Cost of sales 106,186 211,575 Gross margin 50,020 90,301 Selling, general and administrative 28,732 61,477 Restructuring and asset-related charges — — Operating income 21,288 28,824 Interest income, net (414) (685) Other income, net (871) (2,257) Income from discontinued operations before taxes 22,573 31,766 Income tax expense 6,794 9,318 Income from discontinued operations, net of tax $ 15,779 $ 22,448 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows through the divestiture date of July 2, 2023. The following table presents cash flow and non-cash information related to discontinued operations: Six Months Ended (amounts in thousands) July 1, 2023 Depreciation and amortization $ 5,196 Capital expenditures 6,229 Share-based incentive compensation 812 Provision for bad debt 5,062 As of June 29, 2024 and December 31, 2023, the related assets and liabilities included within the summary below were expected to be disposed of within the next twelve months and are included in assets held for sale and liabilities held for sale in the accompanying consolidated balance sheets. (amounts in thousands) June 29, 2024 December 31, 2023 Assets Accounts receivable, net $ 42 $ — Inventories $ 20,133 $ 17,337 Other current assets 150 108 Property and equipment, net 57,965 50,672 Intangible assets, net 1,471 1,471 Goodwill 65,000 65,000 Operating lease assets, net 975 975 Assets held for sale $ 145,736 $ 135,563 Liabilities Accounts payable $ 65 $ — Accrued payroll and benefits $ 1,239 $ 901 Accrued expenses and other current liabilities 6,610 6,126 Operating lease liability 17 37 Liabilities held for sale $ 7,931 $ 7,064

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 29, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor, and manufacturing overhead costs. (amounts in thousands) June 29, 2024 December 31, 2023 Raw materials $ 396,613 $ 404,360 Work in process 20,777 21,141 Finished goods 97,974 84,954 Inventory valuation reserves (27,661) (29,004) Total inventories $ 487,703 $ 481,451

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended
	Jun. 29, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	(amounts in thousands) June 29, 2024 December 31, 2023 Property and equipment $ 1,966,754 $ 1,966,371 Accumulated depreciation (1,313,324) (1,322,129) Total property and equipment, net $ 653,430 $ 644,242 Depreciation expense was recorded as follows: Three Months Ended Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 Cost of sales $ 20,464 $ 30,255 $ 40,462 $ 50,528 Selling, general and administrative 1,127 1,243 2,248 2,888 Total depreciation expense $ 21,591 $ 31,498 $ 42,710 $ 53,416

Goodwill (Tables)

Goodwill (Tables)	6 Months Ended
	Jun. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes the changes in goodwill by reportable segment: (amounts in thousands) North Europe Total Gross carrying amount at December 31, 2023 $ 182,412 $ 268,512 $ 450,924 Foreign currency translation (215) (10,267) (10,482) Gross carrying amount at June 29, 2024 $ 182,197 $ 258,245 $ 440,442 Accumulated impairment losses at December 31, 2023 $ — $ (60,754) $ (60,754) Foreign currency translation — 2,060 2,060 Accumulated impairment losses at June 29, 2024 $ — $ (58,694) $ (58,694) Balance, net of impairment at June 29, 2024 $ 182,197 $ 199,551 $ 381,748

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	6 Months Ended
	Jun. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	The cost and accumulated amortization values of our intangible assets were as follows: June 29, 2024 (amounts in thousands) Cost Accumulated Net Customer relationships and agreements $ 121,437 $ (87,021) $ 34,416 Software 69,837 (26,750) 43,087 Trademarks and trade names 31,739 (11,456) 20,283 Patents, licenses and rights 12,638 (5,043) 7,595 Total amortizable intangibles $ 235,651 $ (130,270) $ 105,381 December 31, 2023 (amounts in thousands) Cost Accumulated Net Customer relationships and agreements $ 123,713 $ (84,281) $ 39,432 Software 113,429 (58,424) 55,005 Trademarks and trade names 32,148 (10,802) 21,346 Patents, licenses and rights 12,666 (4,539) 8,127 Total amortizable intangibles $ 281,956 $ (158,046) $ 123,910
Schedule of Finite-lived Intangible Assets Amortization Expense	Amortization expense was recorded as follows: Three Months Ended Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 Amortization expense $ 4,907 $ 5,999 $ 23,823 $ 12,000

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended
	Jun. 29, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	(amounts in thousands) June 29, 2024 December 31, 2023 Accrued sales and advertising rebates $ 71,725 $ 82,732 Current portion of operating lease liability 34,101 32,477 Non-income related taxes 23,078 20,072 Current portion of warranty liability (Note 9) 21,928 22,819 Accrued freight 17,674 18,963 Current portion of accrued claim costs relating to self-insurance programs 15,810 14,079 Accrued expenses 14,452 15,758 Current portion of restructuring accrual ( Note 16 ) 12,896 3,375 Current portion of uncertain tax positions (Note 11) 10,638 — Legal claims provision ( Note 21 ) 7,159 2,683 Deferred revenue and customer deposits 6,104 7,189 Accrued income taxes payable 5,416 9,252 Accrued interest payable 1,652 1,401 Current portion of derivative liability (Note 19) 733 2,996 Total accrued expenses and other current liabilities $ 243,366 $ 233,796

Warranty Liability (Tables)

Warranty Liability (Tables)	6 Months Ended
	Jun. 29, 2024
Product Warranties Disclosures [Abstract]
Schedule of Analysis of Warranty Liability	An analysis of our warranty liability is as follows: (amounts in thousands) June 29, 2024 July 1, 2023 Balance as of January 1 $ 53,247 $ 52,389 Current period charges 12,740 16,471 Experience adjustments 633 242 Payments (13,307) (15,118) Currency translation (423) 207 Balance at period end 52,890 54,191 Current portion (21,928) (22,788) Long-term portion $ 30,962 $ 31,403

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Jun. 29, 2024
Debt Disclosure [Abstract]
Schedule of Long-Term Debt Instruments	Our long-term debt, net of original issue discount and unamortized debt issuance costs, consisted of the following: June 29, 2024 June 29, 2024 December 31, 2023 (amounts in thousands) Interest Rate Senior Notes 4.63% - 4.88% $ 600,000 $ 600,000 Term Loan Facility 7.44% (1) 533,569 536,250 Finance leases and other financing arrangements 1.00% - 8.95% (1) 65,204 74,460 Mortgage notes 5.68% - 6.18% (1) 20,748 22,070 Total Debt 1,219,521 1,232,780 Unamortized debt issuance costs and original issue discounts (5,135) (6,528) Current maturities of long-term debt (35,384) (36,177) Long-term debt $ 1,179,002 $ 1,190,075 (1)

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 29, 2024
Segment Reporting [Abstract]
Schedule of Segment Reportable Segments, by Segment	The following tables set forth certain information relating to our segments’ operations: (amounts in thousands) North Europe Total Operating Corporate Total Three Months Ended June 29, 2024 Total net revenues $ 710,651 $ 277,081 $ 987,732 $ — $ 987,732 Intersegment net revenues (52) (1,664) (1,716) — (1,716) Net revenues from external customers $ 710,599 $ 275,417 $ 986,016 $ — $ 986,016 Three Months Ended July 1, 2023 Total net revenues $ 817,184 $ 309,562 $ 1,126,746 $ — $ 1,126,746 Intersegment net revenues (72) (907) (979) — (979) Net revenues from external customers $ 817,112 $ 308,655 $ 1,125,767 $ — $ 1,125,767 (amounts in thousands) North Europe Total Operating Corporate Total Six Months Ended June 29, 2024 Total net revenues $ 1,390,653 $ 556,879 $ 1,947,532 $ — $ 1,947,532 Intersegment net revenues (60) (2,330) (2,390) — (2,390) Net revenues from external customers $ 1,390,593 $ 554,549 $ 1,945,142 $ — $ 1,945,142 Six Months Ended July 1, 2023 Total net revenues $ 1,585,306 $ 622,183 $ 2,207,489 $ — $ 2,207,489 Intersegment net revenues (161) (1,039) (1,200) — (1,200) Net revenues from external customers $ 1,585,145 $ 621,144 $ 2,206,289 $ — $ 2,206,289 Three Months Ended June 29, 2024 (amounts in thousands) North America Europe Total Operating Segments Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 30,717 $ (5,025) $ 25,692 $ (44,183) $ (18,491) Income tax expense (benefit) 12,913 10,300 23,213 (13,650) 9,563 Depreciation and amortization 18,900 7,563 26,463 1,786 28,249 Interest expense, net 616 587 1,203 15,361 16,564 Special items: Net legal and professional expenses and settlements 922 1,119 2,041 18,305 20,346 Restructuring and asset-related charges 9,227 6,669 15,896 551 16,447 M&A related costs (42) — (42) 5,095 5,053 Net gain on sale of property and equipment 287 (159) 128 (18) 110 Share-based compensation expense 1,043 101 1,144 3,930 5,074 Non-cash foreign exchange transaction/translation loss (gain) 228 (2,353) (2,125) 933 (1,192) Other special items 826 1,620 2,446 670 3,116 Adjusted EBITDA from continuing operations $ 75,637 $ 20,422 $ 96,059 $ (11,220) $ 84,839 Three Months Ended July 1, 2023 (amounts in thousands) North America Europe Total Operating Segments Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 51,269 $ 10,656 $ 61,925 $ (39,423) $ 22,502 Income tax expense (benefit) 21,127 3,080 24,207 (13,456) 10,751 Depreciation and amortization (1) 27,699 7,499 35,198 3,016 38,214 Interest expense, net 750 417 1,167 19,687 20,854 Special items: Net legal and professional expenses and settlements 2 2,386 2,388 1,998 4,386 Restructuring and asset-related charges 5,658 515 6,173 639 6,812 M&A related costs 321 — 321 948 1,269 Net loss (gain) on sale of property and equipment 360 (192) 168 — 168 Share-based compensation expense 1,492 484 1,976 2,773 4,749 Non-cash foreign exchange transaction/translation (gain) loss (114) 557 443 4 447 Other special items 254 (1,540) (1,286) 5 (1,281) Adjusted EBITDA from continuing operations $ 108,818 $ 23,862 $ 132,680 $ (23,809) $ 108,871 (1) North America depreciation and amortization expense in the three months ended July 1, 2023 includes accelerated depreciation of $9.1 million from reviews of equipment capacity optimization. To conform with current period presentation, certain amounts in prior period information have been reclassified. Six Months Ended June 29, 2024 (amounts in thousands) North America Europe Total Operating Segments Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 47,002 $ (5,003) $ 41,999 $ (88,220) $ (46,221) Income tax expense (benefit) 20,345 13,158 33,503 (27,371) 6,132 Depreciation and amortization (1) 36,891 15,056 51,947 17,731 69,678 Interest expense, net 1,318 931 2,249 30,007 32,256 Special items: Net legal and professional expenses and settlements 1,717 1,372 3,089 34,447 37,536 Restructuring and asset-related charges 23,125 10,625 33,750 756 34,506 M&A related costs — — — 6,178 6,178 Net gain on sale of property and equipment (2,551) (186) (2,737) (18) (2,755) Loss on extinguishment and refinancing of debt — 1,449 1,449 Share-based compensation expense 2,261 648 2,909 7,224 10,133 Non-cash foreign exchange transaction/translation loss (gain) 262 (3,296) (3,034) 296 (2,738) Other special items 6,465 1,620 8,085 (692) 7,393 Adjusted EBITDA from continuing operations $ 136,835 $ 34,925 $ 171,760 $ (18,213) $ 153,547 (1) Corporate and unallocated depreciation and amortization expense includes software accelerated amortization of $14.1 million for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. Six Months Ended July 1, 2023 (amounts in thousands) North America Europe Total Operating Segments Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 86,518 $ 17,955 $ 104,473 $ (73,506) $ 30,967 Income tax expense (benefit) 35,660 4,495 40,155 (25,916) 14,239 Depreciation and amortization (1) 45,497 14,932 60,429 6,128 66,557 Interest expense, net 3,584 545 4,129 38,217 42,346 Special items: Net legal and professional expenses and settlements 2 2,456 2,458 3,750 6,208 Restructuring and asset-related charges 13,470 1,782 15,252 826 16,078 M&A related costs 567 — 567 3,402 3,969 Net loss (gain) on sale of property and equipment 384 (297) 87 — 87 Share-based compensation expense 2,452 983 3,435 5,438 8,873 Non-cash foreign exchange transaction/translation (gain) loss (299) (1,151) (1,450) 282 (1,168) Other special items 181 (201) (20) 52 32 Adjusted EBITDA from continuing operations $ 188,016 $ 41,499 $ 229,515 $ (41,327) $ 188,188 (1) North America depreciation and amortization expense in the six months ended July 1, 2023 includes accelerated depreciation of $9.1 million from reviews of equipment capacity optimization. To conform with current period presentation, certain amounts in prior period information have been reclassified.
Schedule of Reconciliation of Net Income (Loss) to Adjusted EBITDA	Reconciliations of income from continuing operations, net of tax to Adjusted EBITDA from continuing operations are as follows: Three Months Ended Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 (Loss) income from continuing operations, net of tax $ (18,491) $ 22,502 (46,221) 30,967 Income tax expense 9,563 10,751 6,132 14,239 Depreciation and amortization (1) 28,249 38,214 69,678 66,557 Interest expense, net 16,564 20,854 32,256 42,346 Special items: Net legal and professional expenses and settlements (2) 20,346 4,386 37,536 6,208 Restructuring and asset-related charges (3)(4) 16,447 6,812 34,506 16,078 M&A related costs (5) 5,053 1,269 6,178 3,969 Net loss (gain) on sale of property and equipment (6) 110 168 (2,755) 87 Loss on extinguishment and refinancing of debt (7) — — 1,449 — Share-based compensation expense (8) 5,074 4,749 10,133 8,873 Non-cash foreign exchange transaction/translation (gain) loss (9) (1,192) 447 (2,738) (1,168) Other special items (10) 3,116 (1,281) 7,393 32 Adjusted EBITDA from continuing operations $ 84,839 $ 108,871 $ 153,547 $ 188,188 (1) Depreciation and amortization expense in the six months ended June 29, 2024 includes accelerated amortization of $14.1 million in Corporate and unallocated costs for an ERP that we are no longer utilizing after we completed our related obligations under the JW Australia Transition Services Agreement during the first quarter of 2024. Depreciation and amortization expense in the three and six months ended July 1, 2023 includes accelerated depreciation of $9.1 million in North America from reviews of equipment capacity optimization. (2) Net legal and professional expenses and settlements include non-recurring transformation journey expenses of $18.2 million and $34.6 million in the three and six months ended June 29, 2024, respectively, and $3.5 million and $4.9 million in the three and six months ended July 1, 2023, respectively. These expenses primarily relate to the engagement of one transformation consultant for a period spanning third quarter of 2023 through the fourth quarter of 2024, for which we incurred $13.8 million and $28.4 million in the three and six months ended June 29, 2024, respectively, and $0.4 million in the three and six months ended July 1, 2023. Additionally, net legal and professional expenses and settlements include amounts relating to litigation of historic legal matters of $1.5 million and $2.6 million in the three and six months ended June 29, 2024, respectively, and of $1.1 million and $1.4 million and in the three and six months ended July 1, 2023, respectively. (3) Represents severance, accelerated depreciation and amortization, equipment relocation and other expenses directly incurred as a result of restructuring events. The restructuring charges primarily relate to charges incurred to change the operating structure, eliminate certain roles, and close certain manufacturing facilities in our North America and Europe segments. (4) For the three and six months ended June 29, 2024, $6.4 million of product and inventory-related charges related to announced facility closures were detrimental to Adjusted EBITDA. (5) M&A related costs consists primarily of legal and professional expenses related to the potential disposition of Towanda. (6) Net gain on sale of property and equipment, primarily in Chile, in the six months ended June 29, 2024. (7) Loss on extinguishment and refinancing of debt of $1.4 million associated with an amendment of our Term Loan Facility. (8) Represents non-cash equity-based compensation expense related to the issuance of share-based awards. (9) Non-cash foreign exchange transaction/translation gain primarily associated with fair value adjustments of foreign currency derivatives and revaluation of balances denominated in foreign currencies. (10) Other special items not core to ongoing business activity include: (i) in the three months ended June 29, 2024, a one-time realized foreign currency loss of $1.6 million in our Europe segment related to a cash repatriation event; (ii) in the three months ended July 1, 2023, ($2.8) million in compensation and non-income taxes associated with exercises of legacy equity awards in our Europe segment; (iii) in the six months ended June 29, 2024, a loss of $4.3 million of cumulative foreign currency translation adjustments related to the substantial liquidation of a foreign subsidiary in Chile in our North America segment, a one-time realized foreign currency loss of $1.6 million in our Europe segment related to a cash repatriation event, and ($1.5) million of cash received on an impaired note in Corporate and unallocated costs. To conform with current period presentation, certain amounts in prior period information have been reclassified.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 29, 2024
Earnings Per Share [Abstract]
Schedule of Weighted Average Shares Outstanding, Basic and Diluted	The basic and diluted income per share calculations were determined based on the following share data : Three Months Ended Six Months Ended June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 Weighted average outstanding shares of Common Stock basic 85,271,699 84,964,935 85,397,067 84,781,940 Restricted stock units, performance share units and options to purchase Common Stock — 799,850 — 635,404 Weighted average outstanding shares of Common Stock diluted 85,271,699 85,764,785 85,397,067 85,417,344
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income per share as their inclusion would be anti-dilutive: Three Months Ended Six Months Ended June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 Common Stock options 1,265,738 1,755,793 1,243,864 1,714,881 Restricted stock units 1,071,024 6,371 1,181,019 18,197 Performance share units 511,392 317,532 430,981 256,435

Stock Compensation (Tables)

Stock Compensation (Tables)	6 Months Ended
	Jun. 29, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity Roll forward	The activity under our incentive plans for the periods presented are reflected in the following tables: Three Months Ended June 29, 2024 July 1, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted — $ — 26,917 $ 13.15 Options exercised 48,728 $ 9.87 19,715 $ 9.83 Options cancelled 65,331 $ 16.31 70,495 $ 21.30 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 100,177 $ 19.21 154,324 $ 13.70 PSUs granted — $ — 15,209 $ 17.69 Six Months Ended June 29, 2024 July 1, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 365,412 $ 18.52 262,809 $ 13.28 Options exercised 191,908 $ 13.02 19,715 $ 9.83 Options cancelled 74,471 $ 17.67 77,890 $ 21.77 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 936,088 $ 18.60 1,490,329 $ 13.26 PSUs granted 417,347 $ 22.60 307,273 $ 17.38
Schedule of RSU and PSU Activity Roll forward	The activity under our incentive plans for the periods presented are reflected in the following tables: Three Months Ended June 29, 2024 July 1, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted — $ — 26,917 $ 13.15 Options exercised 48,728 $ 9.87 19,715 $ 9.83 Options cancelled 65,331 $ 16.31 70,495 $ 21.30 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 100,177 $ 19.21 154,324 $ 13.70 PSUs granted — $ — 15,209 $ 17.69 Six Months Ended June 29, 2024 July 1, 2023 Shares Weighted Average Exercise Price Per Share Shares Weighted Average Exercise Price Per Share Options granted 365,412 $ 18.52 262,809 $ 13.28 Options exercised 191,908 $ 13.02 19,715 $ 9.83 Options cancelled 74,471 $ 17.67 77,890 $ 21.77 Shares Weighted Average Grant Date Fair Value Shares Weighted Average Grant Date Fair Value RSUs granted 936,088 $ 18.60 1,490,329 $ 13.26 PSUs granted 417,347 $ 22.60 307,273 $ 17.38

Restructuring and Asset-Relat_2

Restructuring and Asset-Related Charges (Tables)	6 Months Ended
	Jun. 29, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Asset Related Costs	The following table summarizes the restructuring and asset-related charges for the periods indicated: (amounts in thousands) North Europe Corporate Total Three Months Ended June 29, 2024 Restructuring severance and employee-related charges $ 2,062 $ 3,877 $ 355 $ 6,294 Other restructuring associated costs 2,018 1,861 — 3,879 Asset-related charges 5,147 931 196 6,274 Other restructuring associated costs and asset-related charges 7,165 2,792 196 10,153 Total restructuring and asset-related charges $ 9,227 $ 6,669 $ 551 $ 16,447 Three Months Ended July 1, 2023 Restructuring severance and employee-related charges $ 286 $ 1,706 $ 639 $ 2,631 Other restructuring associated costs (income) 4,306 (1,191) — 3,115 Asset-related charges 1,066 — — 1,066 Other restructuring associated costs and asset-related charges (income) 5,372 (1,191) — 4,181 Total restructuring and asset-related charges, net $ 5,658 $ 515 $ 639 $ 6,812 (amounts in thousands) North Europe Corporate Total Six Months Ended June 29, 2024 Restructuring severance and employee-related charges $ 10,951 $ 7,275 $ 560 $ 18,786 Other restructuring associated costs 4,108 2,419 — 6,527 Asset-related charges 8,066 931 196 9,193 Other restructuring associated costs and asset-related charges 12,174 3,350 196 15,720 Total restructuring and asset-related charges $ 23,125 $ 10,625 $ 756 $ 34,506 Six Months Ended July 1, 2023 Restructuring severance and employee-related charges $ 3,342 $ 2,793 $ 826 $ 6,961 Other restructuring associated costs (income) 6,891 (1,191) — 5,700 Asset-related charges 3,237 180 — 3,417 Other restructuring associated costs and asset-related charges (income) 10,128 (1,011) — 9,117 Total restructuring and asset-related charges $ 13,470 $ 1,782 $ 826 $ 16,078 Costs and cash outlays associated with the plans: North America: Vista, California and Hawkins, Wisconsin Total Estimated Cumulative Costs in the Three Months Ended Costs in the Six Months Ended (amounts in thousands) Costs Costs to-date June 29, 2024 June 29, 2024 Restructuring severance and employee-related charges (1) $ 11,500 $ 10,546 $ 1,726 $ 10,546 Other restructuring associated costs (1) 7,600 1,355 1,355 1,355 Product-related cash charges (2) 5,000 2,649 2,649 2,649 Total cash charges 24,100 14,550 5,730 14,550 Asset-related charges (1) 9,300 3,215 3,215 3,215 Inventory and other product-related non-cash charges (3) 4,400 3,706 3,706 3,706 Total non-cash charges 13,700 6,921 6,921 6,921 Total costs $ 37,800 $ 21,471 $ 12,651 $ 21,471 Total cash outlays $ 28,100 $ 5,679 $ 5,679 $ 5,679 (1) The charges incurred in the three and six months ended June 29, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. (2) The product-related cash charges incurred in the three and six months ended June 29, 2024 were detrimental to Net Sales in the accompanying Consolidated Statement of Operations. (3) The inventory and other product-related non-cash charges in the three and six months ended June 29, 2024 were included in Cost of Sales in the accompanying Consolidated Statement of Operations. Costs and cash outlays associated with the plans: Europe Total Estimated Cumulative Costs in the Three Months Ended Costs in the Six Months Ended (amounts in thousands) Costs Costs to-date June 29, 2024 June 29, 2024 Restructuring severance and employee-related charges (1) $ 19,200 $ 10,289 $ 3,825 $ 7,207 Other restructuring associated costs (1) 4,400 2,740 1,830 2,316 Total cash charges 23,600 13,029 5,655 9,523 Asset-related non-cash charges (1) 600 573 573 573 Capital expenditures 3,300 1,264 — 1,264 Total costs $ 27,500 $ 14,866 $ 6,228 $ 11,360 Total cash outlays $ 26,900 $ 11,058 $ 4,864 $ 8,943 (1) The charges incurred in the three and six months ended June 29, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. Costs and cash outlays associated with the plans: North America: Tijuana, Mexico and Vista, California Total Estimated Cumulative Costs in the Three Months Ended Costs in the Six Months Ended (amounts in thousands) Costs Costs to-date June 29, 2024 June 29, 2024 Restructuring severance and employee-related charges (1) $ 7,900 $ 7,502 $ 13 $ (311) Other restructuring associated costs (1) 2,700 2,545 322 1,944 Total cash charges 10,600 10,047 335 1,633 Asset-related charges (1) 6,600 6,628 — 2,919 Inventory and other product-related non-cash charges (2) 1,500 1,466 — — Total non-cash charges 8,100 8,094 — 2,919 Total costs $ 18,700 $ 18,141 $ 335 $ 4,552 Total cash outlays $ 10,600 $ 9,187 $ 471 $ 2,560 (1) The related charges incurred in the three and six months ended June 29, 2024 were included in restructuring and asset-related charges in the accompanying Consolidated Statement of Operations. (2) The inventory and other product-related non-cash charges incurred during 2023 were included in Cost of Sales in the Consolidated Statement of Operations.
Schedule of Restructuring Reserve by Type of Cost	The following is a summary of the restructuring accruals recorded and charges incurred: (amounts in thousands) June 29, 2024 July 1, 2023 Balance as of January 1 $ 3,375 $ 5,021 Current period charges 25,313 12,661 Payments (15,586) (15,067) Currency translation (206) 75 Balance at period end $ 12,896 $ 2,690

Held for Sale (Tables)

Held for Sale (Tables)	6 Months Ended
	Jun. 29, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Accompanying Balance Sheet	Components of amounts reflected in the consolidated statements of operations related to discontinued operations are presented in the table, as follows: Three Months Ended Six Months Ended (amounts in thousands) July 1, 2023 July 1, 2023 Net revenues $ 156,206 $ 301,876 Cost of sales 106,186 211,575 Gross margin 50,020 90,301 Selling, general and administrative 28,732 61,477 Restructuring and asset-related charges — — Operating income 21,288 28,824 Interest income, net (414) (685) Other income, net (871) (2,257) Income from discontinued operations before taxes 22,573 31,766 Income tax expense 6,794 9,318 Income from discontinued operations, net of tax $ 15,779 $ 22,448 The cash flows related to discontinued operations have not been segregated and are included in the consolidated statements of cash flows through the divestiture date of July 2, 2023. The following table presents cash flow and non-cash information related to discontinued operations: Six Months Ended (amounts in thousands) July 1, 2023 Depreciation and amortization $ 5,196 Capital expenditures 6,229 Share-based incentive compensation 812 Provision for bad debt 5,062 As of June 29, 2024 and December 31, 2023, the related assets and liabilities included within the summary below were expected to be disposed of within the next twelve months and are included in assets held for sale and liabilities held for sale in the accompanying consolidated balance sheets. (amounts in thousands) June 29, 2024 December 31, 2023 Assets Accounts receivable, net $ 42 $ — Inventories $ 20,133 $ 17,337 Other current assets 150 108 Property and equipment, net 57,965 50,672 Intangible assets, net 1,471 1,471 Goodwill 65,000 65,000 Operating lease assets, net 975 975 Assets held for sale $ 145,736 $ 135,563 Liabilities Accounts payable $ 65 $ — Accrued payroll and benefits $ 1,239 $ 901 Accrued expenses and other current liabilities 6,610 6,126 Operating lease liability 17 37 Liabilities held for sale $ 7,931 $ 7,064

Other (Income) Expense, Net (Ta

Other (Income) Expense, Net (Tables)	6 Months Ended
	Jun. 29, 2024
Other Income and Expenses [Abstract]
Schedule of Other Expense (Income), Net	The table below summarizes the amounts included in other income, net in the accompanying consolidated statements of operations: Three Months Ended Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 JW Australia Transition Services Agreement cost recovery $ (2,402) $ — $ (6,542) $ — Foreign currency losses (gains), net 632 (231) (835) (2,102) Pension expense 513 1,657 1,028 3,351 Cash received on investment in real estate (379) — (2,527) — Recovery of cost from receipts on impaired notes — (281) (1,389) (1,675) Governmental assistance (270) (44) (927) (191) Income from refund of deposits for China antidumping and countervailing duties (1) — — (2,947) — Insurance reimbursement — — (1,655) (1,234) Other items, net (582) 1,058 (957) 323 Total other income, net $ (2,488) $ 2,159 $ (16,751) $ (1,528) (1) Represents the refund of deposits for antidumping and countervailing duties on wood mouldings and millwork products purchased from China from 2020 to 2022.

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	6 Months Ended
	Jun. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The fair values of derivative instruments held are as follows: Derivative assets (amounts in thousands) Balance Sheet Location June 29, 2024 December 31, 2023 Derivatives designated as hedging instruments: Interest rate contracts Other current assets $ 473 $ — Derivatives not designated as hedging instruments: Foreign currency forward contracts Other current assets $ 491 $ 1,186 Other derivative instruments Other current assets $ 63 $ 38 Derivative liabilities (amounts in thousands) Balance Sheet Location June 29, 2024 December 31, 2023 Derivatives designated as hedging instruments: Interest rate contracts Deferred credits and other liabilities $ 37 $ — Derivatives not designated as hedging instruments: Foreign currency forward contracts Accrued expenses and other current liabilities $ 733 $ 2,975 Other derivative instruments Accrued expenses and other current liabilities $ — 21

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 29, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The recorded carrying amounts and fair values of these instruments were as follows: June 29, 2024 (amounts in thousands) Carrying Amount Total Level 1 Level 2 Level 3 Assets: Cash equivalents $ 158,953 $ 158,953 $ 158,953 $ — $ — Derivative assets, recorded in other current assets 1,027 1,027 — 1,027 — Deferred compensation plan assets, recorded in other assets 4,485 4,485 — 4,485 — Liabilities: Debt, recorded in long-term debt and current maturities of long-term debt $ 1,219,521 $ 1,196,522 $ — $ 1,196,522 $ — Derivative liabilities, recorded in accrued expenses and other current liabilities 733 733 — 733 — Derivative liabilities, recorded in deferred credits and other liabilities 37 37 — 37 — December 31, 2023 (amounts in thousands) Carrying Amount Total Level 1 Level 2 Level 3 Assets: Cash equivalents $ 71,139 $ 71,139 $ 71,139 $ — $ — Derivative assets, recorded in other current assets 1,224 1,224 — 1,224 — Deferred compensation plan assets, recorded in other assets 2,098 2,098 — 2,098 — Liabilities: Debt, recorded in long-term debt and current maturities of long-term debt $ 1,232,780 $ 1,209,961 $ — $ 1,209,961 $ — Derivative liabilities, recorded in accrued expenses and other current assets 2,996 2,996 — 2,996 —

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	6 Months Ended
	Jun. 29, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures	Six Months Ended (amounts in thousands) June 29, 2024 July 1, 2023 Cash Operating Activities: Operating leases $ 24,622 $ 29,970 Interest payments on financing lease obligations 225 106 Cash paid for amounts included in the measurement of lease liabilities $ 24,847 $ 30,076 Cash Investing Activities: Purchases of securities for deferred compensation plan $ (2,817) $ (770) Sale of securities for deferred compensation plan — 111 Change in securities for deferred compensation plan $ (2,817) $ (659) Cash received on notes receivable 2 — Change in notes receivable $ 2 $ — Non-cash Investing Activities: Property, equipment, and intangibles purchased in accounts payable $ 12,698 $ 5,591 Property, equipment, and intangibles purchased with debt 3,518 7,405 Customer accounts receivable converted to notes receivable 10 96 Cash Financing Activities: Borrowings on long-term debt $ 1,225 $ 126,933 Payments of long-term debt (16,803) (197,259) Payments of debt issuance and extinguishment costs, including underwriting fees (198) — Change in long-term debt and payments of debt extinguishment costs $ (15,776) $ (70,326) Cash paid for amounts included in the measurement of finance lease liabilities $ 1,195 $ 985 Non-cash Financing Activities: Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities $ — $ 732 Accounts payable converted to installment notes 5 176 Other Supplemental Cash Flow Information: Cash taxes paid, net of refunds $ 17,332 $ 25,839 Cash interest paid 39,520 41,859

Description of Company and Su_3

Description of Company and Summary of Significant Accounting Policies (Details) $ in Millions	3 Months Ended
	Dec. 31, 2023 USD ($)
Cares Act, Deferral of Social Security Tax
Unusual or Infrequent Item, or Both [Line Items]
Other operating income (expense), net	$ 6.1

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) - JW Australia $ in Millions, $ in Millions	Jun. 29, 2024 USD ($)	Dec. 31, 2023 USD ($)	Jul. 02, 2023 USD ($)	Apr. 17, 2023 AUD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Transition services liability	$ 4.5	$ 8.2
Accrued expenses and other current liabilities		$ 6.1
Disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Adjustment of purchase price			$ 446	$ 688
Cash received from the settlement			$ 3.3

Discontinued Operations- Result

Discontinued Operations- Results of Operations (Details) - Held-for-sale - JW Australia - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 01, 2023	Jul. 01, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net revenues	$ 156,206	$ 301,876
Cost of sales	106,186	211,575
Gross margin	50,020	90,301
Selling, general and administrative	28,732	61,477
Restructuring and asset-related charges	0	0
Operating income	21,288	28,824
Interest income, net	(414)	(685)
Other income, net	(871)	(2,257)
Income from discontinued operations before taxes	22,573	31,766
Income tax expense	6,794	9,318
Income from discontinued operations, net of tax	$ 15,779	$ 22,448

Discontinued Operations- Inform

Discontinued Operations- Information Regarding Cash Flows (Details) - Held-for-sale - JW Australia $ in Thousands	6 Months Ended
	Jul. 01, 2023 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and amortization	$ 5,196
Capital expenditures	6,229
Share-based incentive compensation	812
Provision for bad debt	$ 5,062

Accounts Receivable (Details)

Accounts Receivable (Details) - USD ($) $ in Millions	Jun. 29, 2024	Dec. 31, 2023
Receivables [Abstract]
Allowance for doubtful accounts	$ (9.8)	$ (11.3)

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 396,613	$ 404,360
Work in process	20,777	21,141
Finished goods	97,974	84,954
Inventory valuation reserves	(27,661)	(29,004)
Total inventories	$ 487,703	$ 481,451

Property and Equipment, Net - S

Property and Equipment, Net - Summary (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property and equipment	$ 1,966,754	$ 1,966,371
Accumulated depreciation	(1,313,324)	(1,322,129)
Total property and equipment, net	$ 653,430	$ 644,242

Property and Equipment, Net - N

Property and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Property, Plant and Equipment [Line Items]
Impairment of assets		$ 9.1		$ 9.1
Loss due to currency translations for foreign assets			$ 7.2
Property, plant and equipment
Property, Plant and Equipment [Line Items]
Impairment of assets	$ 5.8	$ 1.1	$ 5.8	$ 3.2

Property and Equipment, Net - D

Property and Equipment, Net - Depreciation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Property, Plant and Equipment [Line Items]
Total depreciation expense	$ 21,591	$ 31,498	$ 42,710	$ 53,416
Cost of sales
Property, Plant and Equipment [Line Items]
Total depreciation expense	20,464	30,255	40,462	50,528
Selling, general and administrative
Property, Plant and Equipment [Line Items]
Total depreciation expense	$ 1,127	$ 1,243	$ 2,248	$ 2,888

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Dec. 31, 2023
Goodwill, Gross [Roll Forward]
Goodwill, gross beginning balance	$ 450,924
Foreign currency translation	(10,482)
Goodwill, gross ending balance	440,442
Goodwill, Impaired, Accumulated Impairment Loss [Roll Forward]
Goodwill, accumulated impairment loss beginning balance	(60,754)
Foreign currency translation	2,060
Goodwill, accumulated impairment loss ending balance	(58,694)
Balance, net of impairment at June 29, 2024	381,748	$ 390,170
North America
Goodwill, Gross [Roll Forward]
Goodwill, gross beginning balance	182,412
Foreign currency translation	(215)
Goodwill, gross ending balance	182,197
Goodwill, Impaired, Accumulated Impairment Loss [Roll Forward]
Goodwill, accumulated impairment loss beginning balance	0
Foreign currency translation	0
Goodwill, accumulated impairment loss ending balance	0
Balance, net of impairment at June 29, 2024	182,197
Europe
Goodwill, Gross [Roll Forward]
Goodwill, gross beginning balance	268,512
Foreign currency translation	(10,267)
Goodwill, gross ending balance	258,245
Goodwill, Impaired, Accumulated Impairment Loss [Roll Forward]
Goodwill, accumulated impairment loss beginning balance	(60,754)
Foreign currency translation	2,060
Goodwill, accumulated impairment loss ending balance	(58,694)
Balance, net of impairment at June 29, 2024	$ 199,551

Intangible Assets, Net - Cost a

Intangible Assets, Net - Cost and Accumulated Amortization (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets
Cost	$ 235,651	$ 281,956
Accumulated Amortization	(130,270)	(158,046)
Net Book Value	105,381	123,910
Customer relationships and agreements
Finite-Lived Intangible Assets
Cost	121,437	123,713
Accumulated Amortization	(87,021)	(84,281)
Net Book Value	34,416	39,432
Software
Finite-Lived Intangible Assets
Cost	69,837	113,429
Accumulated Amortization	(26,750)	(58,424)
Net Book Value	43,087	55,005
Trademarks and trade names
Finite-Lived Intangible Assets
Cost	31,739	32,148
Accumulated Amortization	(11,456)	(10,802)
Net Book Value	20,283	21,346
Patents, licenses and rights
Finite-Lived Intangible Assets
Cost	12,638	12,666
Accumulated Amortization	(5,043)	(4,539)
Net Book Value	$ 7,595	$ 8,127

Intangible Assets, Net - Narrat

Intangible Assets, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Finite-Lived Intangible Assets
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]			Selling, general and administrative
Currency translation decrease			$ 0.7
Software
Finite-Lived Intangible Assets
Finite lived intangible assets written off	$ 14.1	$ 9.1	$ 14.1	$ 9.1

Intangible Assets, Net - Amorti

Intangible Assets, Net - Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 4,907	$ 5,999	$ 23,823	$ 12,000

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023	Jul. 01, 2023
Accounts Payable and Accrued Liabilities, Current
Accrued sales and advertising rebates	$ 71,725	$ 82,732
Current portion of operating lease liability	34,101	32,477
Non-income related taxes	23,078	20,072
Current portion of warranty liability (Note 9)	21,928	22,819	$ 22,788
Accrued freight	17,674	18,963
Current portion of accrued claim costs relating to self-insurance programs	15,810	14,079
Accrued expenses	14,452	15,758
Current portion of restructuring accrual (Note 16)	12,896	3,375
Current portion of uncertain tax positions (Note 11)	10,638	0
Legal claims provision (Note 21)	7,159	2,683
Deferred revenue and customer deposits	6,104	7,189
Accrued income taxes payable	5,416	9,252
Accrued interest payable	1,652	1,401
Current portion of derivative liability (Note 19)	733	2,996
Total accrued expenses and other current liabilities	$ 243,366	$ 233,796

Warranty Liability - Narrative

Warranty Liability - Narrative (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Dec. 31, 2023	Jul. 01, 2023	Dec. 31, 2022
Product Warranty Liability
Accrued warranty liability	$ 52,890	$ 53,247	$ 54,191	$ 52,389
Product warranty, discount adjustment	3,500
North America
Product Warranty Liability
Accrued warranty liability	$ 46,700
Minimum
Product Warranty Liability
Product warranty term (in years)	1 year
Product warranty discount rate (as a percent)	0.53%
Maximum
Product Warranty Liability
Product warranty term (in years)	10 years
Product warranty discount rate (as a percent)	4.23%

Warranty Liability - Analysis o

Warranty Liability - Analysis of Warranty Liability (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Dec. 31, 2023
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease)
Balance at beginning balance	$ 53,247	$ 52,389
Current period charges	12,740	16,471
Experience adjustments	633	242
Payments	(13,307)	(15,118)
Currency translation	(423)	207
Balance at ending balance	52,890	54,191
Current portion	(21,928)	(22,788)	$ (22,819)
Long-term portion	$ 30,962	$ 31,403

Long-Term Debt - Long Term Debt

Long-Term Debt - Long Term Debt (Details) $ in Thousands, kr in Millions	Jun. 29, 2024 USD ($)	Jun. 29, 2024 DKK (kr)	Dec. 31, 2023 USD ($)
Debt Instrument
Total Debt	$ 1,219,521		$ 1,232,780
Unamortized debt issuance costs and original issue discounts	(5,135)		(6,528)
Current maturities of long-term debt	(35,384)		(36,177)
Long-term debt	1,179,002		1,190,075
Senior Notes
Debt Instrument
Long-term debt, gross	600,000		600,000
Term Loan Facility | Term Loans
Debt Instrument
Long-term debt, gross	533,569		536,250
Finance leases and other financing arrangements
Debt Instrument
Finance leases and other financing arrangements	65,204		74,460
Mortgage notes
Debt Instrument
Long-term debt, gross	$ 20,700	kr 144.6	$ 22,070
Minimum | Senior Notes
Debt Instrument
Effective interest rate (as a percent)	4.63%	4.63%
Minimum | Finance leases and other financing arrangements
Debt Instrument
Finance lease, rate (as a percent)	1%	1%
Minimum | Mortgage notes
Debt Instrument
Effective interest rate (as a percent)	5.68%	5.68%
Maximum | Senior Notes
Debt Instrument
Effective interest rate (as a percent)	4.88%	4.88%
Maximum | Term Loan Facility | Term Loans
Debt Instrument
Effective interest rate (as a percent)	7.44%	7.44%
Maximum | Finance leases and other financing arrangements
Debt Instrument
Finance lease, rate (as a percent)	8.95%	8.95%
Maximum | Mortgage notes
Debt Instrument
Effective interest rate (as a percent)	6.18%	6.18%

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details) kr in Millions

1 Months Ended

3 Months Ended

6 Months Ended

Jan. 31, 2024 USD ($) Rate

Jul. 31, 2021 USD ($)

Dec. 31, 2007

Jun. 29, 2024 USD ($)

Sep. 30, 2023 USD ($)

Jul. 01, 2023 USD ($)

Jun. 29, 2024 USD ($) Rate

Jul. 01, 2023 USD ($)

Jun. 29, 2024 DKK (kr)

Feb. 29, 2024 USD ($)

Dec. 31, 2023 USD ($)

Aug. 03, 2023 USD ($)

Jun. 30, 2023 Rate

May 31, 2020 USD ($)

Dec. 31, 2017 USD ($) tranche

Debt Instrument

Amortization of deferred financing costs

$ 869,000

$ 1,572,000

Gain (loss) on extinguishment of debt

$ 0

$ 0

1,449,000

$ 0

Unamortized debt issuance costs and original issue discounts

5,135,000

5,135,000

$ 6,528,000

Long-term debt

0

0

Cash flow hedge | Designated as hedging instrument

Debt Instrument

Derivative fixed interest rate (as a percent)

0.317%

Interest rate swap | Cash flow hedge | Designated as hedging instrument

Debt Instrument

Derivative fixed interest rate (as a percent)

0.317%

0.395%

Notional amount

$ 370,000,000

Interest Rate Cap | Cash flow hedge | Designated as hedging instrument

Debt Instrument

Derivative fixed interest rate (as a percent)

4.50%

Notional amount

$ 100,000,000

$ 370,000,000

SOFR | Minimum | Interest Rate Cap | Cash flow hedge | Designated as hedging instrument

Debt Instrument

Derivative variable interest rate (as a percent)

3.982%

SOFR | Maximum | Interest rate swap | Cash flow hedge | Designated as hedging instrument

Debt Instrument

Derivative variable interest rate (as a percent)

0.10%

SOFR | Maximum | Interest Rate Cap | Cash flow hedge | Designated as hedging instrument

Debt Instrument

Derivative variable interest rate (as a percent)

3.895%

LIBOR | Minimum | Interest rate swap | Cash flow hedge | Designated as hedging instrument

Debt Instrument

Derivative variable interest rate (as a percent)

0.10%

0%

Senior Notes

Debt Instrument

Debt instrument face amount

$ 800,000,000

Number of tranches (in tranches) | tranche

2

Pre-tax loss redemption amount

$ 6,500,000

In call premium

3,900,000

Amortization of deferred financing costs

2,600,000

Long-term debt

600,000,000

600,000,000

600,000,000

Senior Notes | Minimum

Debt Instrument

Debt instrument face amount

$ 250,000,000

Senior Notes | Maximum

Debt Instrument

Debt instrument face amount

$ 200,000,000

Secured debt

Debt Instrument

Debt instrument term (in years)

30 years

Long-term debt

20,700,000

20,700,000

kr 144.6

22,070,000

Letter of credit | Revolving credit facility

Debt Instrument

Letters of credit

2,800,000

2,800,000

Senior Secured Notes Maturing May 2025 | Senior Notes

Debt Instrument

Debt instrument stated interest rate (as a percent)

6.25%

6.25%

4.63%

Senior secured notes

$ 250,000,000

Debt instrument discount rate (as a percent)

1.25%

Senior Note Maturing December 2025 | Senior Notes

Debt Instrument

Debt instrument face amount

$ 400,000,000

Senior Note Maturing December 2027 | Senior Notes

Debt Instrument

Debt instrument face amount

$ 400,000,000

Debt instrument stated interest rate (as a percent)

4.88%

U.S. Facility | Secured debt

Debt Instrument

Debt instrument face amount

$ 550,000,000

U.S. Facility | Secured debt | Corporate credit rating

Debt Instrument

Derivative variable interest rate (as a percent)

0%

U.S. Facility | Secured debt | Corporate credit rating | Minimum

Debt Instrument

Debt instrument, variable rate (as a percent)

2%

U.S. Facility | Secured debt | Corporate credit rating | Maximum

Debt Instrument

Debt instrument, variable rate (as a percent)

2.25%

Term Loans

Debt Instrument

Unamortized debt issuance costs

$ 800,000

Term Loans | SOFR | Minimum

Debt Instrument

Debt instrument, variable rate (as a percent) | Rate

1.75%

Term Loans | SOFR | Maximum

Debt Instrument

Debt instrument, variable rate (as a percent) | Rate

2%

Term Loans | Term loans

Debt Instrument

Premium payable (as a percent)

1%

Repayment (as a percent)

0.25%

Gain (loss) on extinguishment of debt

$ 1,400,000

Long term debt principal amount outstanding

532,900,000

532,900,000

Long-term debt

533,569,000

$ 533,569,000

$ 536,250,000

ABL Facility | Revolving credit facility

Debt Instrument

Derivative variable interest rate (as a percent)

0%

Line fee (as a percent) | Rate

0.25%

Maximum borrowing capacity

$ 500,000,000

ABL Facility | Revolving credit facility | US borrowers

Debt Instrument

Maximum borrowing capacity

465,000,000

ABL Facility | Revolving credit facility | Canadian borrowers

Debt Instrument

Maximum borrowing capacity

$ 35,000,000

ABL Facility | Revolving credit facility | LIBOR | Minimum

Debt Instrument

Debt instrument, variable rate (as a percent)

1.25%

ABL Facility | Revolving credit facility | LIBOR | Maximum

Debt Instrument

Debt instrument, variable rate (as a percent)

1.50%

ABL Facility | Revolving credit facility | Base rate | Minimum

Debt Instrument

Debt instrument, variable rate (as a percent)

0.25%

ABL Facility | Revolving credit facility | Base rate | Maximum

Debt Instrument

Debt instrument, variable rate (as a percent)

0.50%

ABL Facility | Line of credit | Revolving credit facility

Debt Instrument

Borrowing availability

$ 478,800,000

$ 478,800,000

Interest rate swap | Cash flow hedge | Designated as hedging instrument

Debt Instrument

Derivative fixed interest rate (as a percent)

0.395%

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Effective tax rate (as a percent)	(107.10%)	32.30%	(15.30%)	31.50%
Income tax expense (benefit)	$ 9,563	$ 10,751	$ 6,132	$ 14,239
Discrete adjustment expense (benefit)	9,400	1,500	12,100	$ 2,600
Increase in uncertain tax positions	7,700		9,700
Adjustments and settlements, expense (benefit)	2,300	1,500	2,200
Increase for tax positions taken during the prior period		$ 1,200
Unrecognized tax benefits	45,300		45,300		$ 38,900
Current portion of uncertain tax positions (Note 11)	$ 10,638		$ 10,638		$ 0

Segment Information - Narrative

Segment Information - Narrative (Details)	6 Months Ended
	Jun. 29, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Information - Reportabl

Segment Information - Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Segment Reporting Information [Line Items]
Net revenues	$ 986,016	$ 1,125,767	$ 1,945,142	$ 2,206,289
(Loss) income from continuing operations, net of tax	(18,491)	22,502	(46,221)	30,967
Income tax expense (benefit)	9,563	10,751	6,132	14,239
Depreciation and amortization	28,249	38,214	69,678	66,557
Interest expense, net	16,564	20,854	32,256	42,346
Net legal and professional expenses and settlements	20,346	4,386	37,536	6,208
Restructuring Costs and Asset Impairment Charges	16,447	6,812	34,506	16,078
M&A related costs	5,053	1,269	6,178	3,969
Net gain on sale of property and equipment	110	168	(2,755)	87
Loss on extinguishment and refinancing of debt (Note 10)	0	0	1,449	0
Share-based compensation expense	5,074	4,749	10,133	8,873
Non-cash foreign exchange transaction/translation loss (gain)	(1,192)	447	(2,738)	(1,168)
Other special items	3,116	(1,281)	7,393	32
Adjusted EBITDA from continuing operations	84,839	108,871	153,547	188,188
Impairment of assets		9,100		9,100
Software
Segment Reporting Information [Line Items]
Finite lived intangible assets written off	14,100	9,100	14,100	9,100
North America
Segment Reporting Information [Line Items]
Net revenues	710,599	817,112	1,390,593	1,585,145
Europe
Segment Reporting Information [Line Items]
Net revenues	275,417	308,655	554,549	621,144
Operating segments
Segment Reporting Information [Line Items]
Net revenues	987,732	1,126,746	1,947,532	2,207,489
(Loss) income from continuing operations, net of tax	25,692	61,925	41,999	104,473
Income tax expense (benefit)	23,213	24,207	33,503	40,155
Depreciation and amortization	26,463	35,198	51,947	60,429
Interest expense, net	1,203	1,167	2,249	4,129
Net legal and professional expenses and settlements	2,041	2,388	3,089	2,458
Restructuring Costs and Asset Impairment Charges	15,896	6,173	33,750	15,252
M&A related costs	(42)	321	0	567
Net gain on sale of property and equipment	128	168	(2,737)	87
Loss on extinguishment and refinancing of debt (Note 10)			0
Share-based compensation expense	1,144	1,976	2,909	3,435
Non-cash foreign exchange transaction/translation loss (gain)	(2,125)	443	(3,034)	(1,450)
Other special items	2,446	(1,286)	8,085	(20)
Adjusted EBITDA from continuing operations	96,059	132,680	171,760	229,515
Operating segments | North America
Segment Reporting Information [Line Items]
Net revenues	710,651	817,184	1,390,653	1,585,306
(Loss) income from continuing operations, net of tax	30,717	51,269	47,002	86,518
Income tax expense (benefit)	12,913	21,127	20,345	35,660
Depreciation and amortization	18,900	27,699	36,891	45,497
Interest expense, net	616	750	1,318	3,584
Net legal and professional expenses and settlements	922	2	1,717	2
Restructuring Costs and Asset Impairment Charges	9,227	5,658	23,125	13,470
M&A related costs	(42)	321	0	567
Net gain on sale of property and equipment	287	360	(2,551)	384
Loss on extinguishment and refinancing of debt (Note 10)
Share-based compensation expense	1,043	1,492	2,261	2,452
Non-cash foreign exchange transaction/translation loss (gain)	228	(114)	262	(299)
Other special items	826	254	6,465	181
Adjusted EBITDA from continuing operations	75,637	108,818	136,835	188,016
Operating segments | Europe
Segment Reporting Information [Line Items]
Net revenues	277,081	309,562	556,879	622,183
(Loss) income from continuing operations, net of tax	(5,025)	10,656	(5,003)	17,955
Income tax expense (benefit)	10,300	3,080	13,158	4,495
Depreciation and amortization	7,563	7,499	15,056	14,932
Interest expense, net	587	417	931	545
Net legal and professional expenses and settlements	1,119	2,386	1,372	2,456
Restructuring Costs and Asset Impairment Charges	6,669	515	10,625	1,782
M&A related costs	0	0	0	0
Net gain on sale of property and equipment	(159)	(192)	(186)	(297)
Loss on extinguishment and refinancing of debt (Note 10)
Share-based compensation expense	101	484	648	983
Non-cash foreign exchange transaction/translation loss (gain)	(2,353)	557	(3,296)	(1,151)
Other special items	1,620	(1,540)	1,620	(201)
Adjusted EBITDA from continuing operations	20,422	23,862	34,925	41,499
Intersegment net revenues
Segment Reporting Information [Line Items]
Net revenues	(1,716)	(979)	(2,390)	(1,200)
Intersegment net revenues | North America
Segment Reporting Information [Line Items]
Net revenues	(52)	(72)	(60)	(161)
Intersegment net revenues | Europe
Segment Reporting Information [Line Items]
Net revenues	(1,664)	(907)	(2,330)	(1,039)
Corporate and Unallocated Costs
Segment Reporting Information [Line Items]
Net revenues	0	0	0	0
(Loss) income from continuing operations, net of tax	(44,183)	(39,423)	(88,220)	(73,506)
Income tax expense (benefit)	(13,650)	(13,456)	(27,371)	(25,916)
Depreciation and amortization	1,786	3,016	17,731	6,128
Interest expense, net	15,361	19,687	30,007	38,217
Net legal and professional expenses and settlements	18,305	1,998	34,447	3,750
Restructuring Costs and Asset Impairment Charges	551	639	756	826
M&A related costs	5,095	948	6,178	3,402
Net gain on sale of property and equipment	(18)	0	(18)	0
Loss on extinguishment and refinancing of debt (Note 10)			1,449
Share-based compensation expense	3,930	2,773	7,224	5,438
Non-cash foreign exchange transaction/translation loss (gain)	933	4	296	282
Other special items	670	5	(692)	52
Adjusted EBITDA from continuing operations	$ (11,220)	$ (23,809)	$ (18,213)	$ (41,327)

Segment Information - Reconcili

Segment Information - Reconciliation of Net Income (Loss) to EBITDA (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 31, 2024	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Segment Reporting Information [Line Items]
(Loss) income from continuing operations, net of tax		$ (18,491)	$ 22,502	$ (46,221)	$ 30,967
Income tax expense (benefit)		9,563	10,751	6,132	14,239
Depreciation and amortization		28,249	38,214	69,678	66,557
Interest expense, net		16,564	20,854	32,256	42,346
Net legal and professional expenses and settlements		20,346	4,386	37,536	6,208
Restructuring and asset-related charges (Note 16)		16,447	6,812	34,506	16,078
M&A related costs		5,053	1,269	6,178	3,969
Net loss (gain) on sale of property and equipment		110	168	(2,755)	87
Loss on extinguishment and refinancing of debt (Note 10)		0	0	1,449	0
Share-based compensation expense		5,074	4,749	10,133	8,873
Non-cash foreign exchange transaction/translation (gain) loss		(1,192)	447	(2,738)	(1,168)
Other special items		3,116	(1,281)	7,393	32
Adjusted EBITDA from continuing operations		84,839	108,871	153,547	188,188
Non-recurring transformation journey expenses		18,200	3,500	34,600	4,900
Transformation consultant		13,800	400	28,400	400
Litigation settlement, expense		1,500	1,100	2,600	1,400
Product and inventory charges related to EBITDA		6,400		6,400
Gain (loss) on foreign equity compensation				(4,300)
Foreign equity compensation			$ (2,800)		(2,800)
Cash received on impaired note					$ 1,500
North America
Segment Reporting Information [Line Items]
Gain (loss) on foreign equity compensation		$ (1,600)
Term Loans | Term Loan Facility
Segment Reporting Information [Line Items]
Loss on extinguishment and refinancing of debt (Note 10)	$ 1,400
Gain (loss) on extinguishment of debt, amendment				$ 1,400

Capital Stock (Details)

Capital Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended
	Jun. 29, 2024	Jun. 29, 2024	Dec. 31, 2023	Jul. 28, 2022	Jul. 27, 2022
Equity [Abstract]
Shares held in employee trust (in shares)	193,941	193,941	193,941
Shares held in employee trust	$ 12.4	$ 12.4	$ 12.4
Share authorized for repurchase	$ 175.7	$ 175.7		$ 200	$ 400
Common shares repurchased (in shares)	1,600,000	1,600,000
Repurchased common stock average price (in dollars per share)	$ 15.18	$ 15.18

Earnings Per Share - Basic and

Earnings Per Share - Basic and Diluted Income Per Share Calculations (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Earnings Per Share [Abstract]
Weighted average outstanding shares of Common Stock basic (in shares)	85,271,699	84,964,935	85,397,067	84,781,940
Restricted stock units and options to purchase Common Stock (in shares)	0	799,850	0	635,404
Weighted average outstanding shares of Common Stock diluted (in shares)	85,271,699	85,764,785	85,397,067	85,417,344

Earnings Per Share - Potentiall

Earnings Per Share - Potentially Dilutive Securities (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Common Stock options
Incremental Weighted Average Shares Attributable to Dilutive Effect
Antidilutive securities excluded from computation of diluted earnings per share (in shares)	1,265,738	1,755,793	1,243,864	1,714,881
Restricted stock units
Incremental Weighted Average Shares Attributable to Dilutive Effect
Antidilutive securities excluded from computation of diluted earnings per share (in shares)	1,071,024	6,371	1,181,019	18,197
Performance share units
Incremental Weighted Average Shares Attributable to Dilutive Effect
Antidilutive securities excluded from computation of diluted earnings per share (in shares)	511,392	317,532	430,981	256,435

Stock Compensation - Activity (

Stock Compensation - Activity (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options granted (in shares)	0	26,917	365,412	262,809
Options exercised (in shares)	48,728	19,715	191,908	19,715
Options canceled (in shares)	65,331	70,495	74,471	77,890
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Options granted (usd per share)	$ 0	$ 13.15	$ 18.52	$ 13.28
Options exercised (usd per share)	9.87	9.83	13.02	9.83
Options canceled (usd per share)	$ 16.31	$ 21.30	$ 17.67	$ 21.77
RSUs
Weighted Average Grant-Date Fair Value Per Share
Equity instruments granted (in shares)	100,177	154,324	936,088	1,490,329
Equity instruments granted, weighted average exercise price (usd per share)	$ 19.21	$ 13.70	$ 18.60	$ 13.26
PSU's
Weighted Average Grant-Date Fair Value Per Share
Equity instruments granted (in shares)	0	15,209	417,347	307,273
Equity instruments granted, weighted average exercise price (usd per share)	$ 0	$ 17.69	$ 22.60	$ 17.38

Stock Compensation - Narrative

Stock Compensation - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Share-based Compensation Arrangement by Share-based Payment Award
Stock-based compensation	$ 5	$ 4.8	$ 10.1	$ 8.9
Performance share units
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation not yet recognized	$ 26.7		$ 26.7
Recognition period for stock compensation not yet recognized (in years)			1 year 8 months 8 days

Restructuring and Asset-Relat_3

Restructuring and Asset-Related Charges - Impairment by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Restructuring Cost and Reserve
Restructuring severance and employee-related charges	$ 6,294	$ 2,631	$ 18,786	$ 6,961
Other restructuring associated costs	3,879	3,115	6,527	5,700
Asset-related charges	6,274	1,066	9,193	3,417
Other restructuring associated costs and asset-related charges	10,153	4,181	15,720	9,117
Total restructuring and asset-related charges, net	16,447	6,812	34,506	16,078
Operating segments
Restructuring Cost and Reserve
Total restructuring and asset-related charges, net	15,896	6,173	33,750	15,252
Operating segments | North America
Restructuring Cost and Reserve
Restructuring severance and employee-related charges	2,062	286	10,951	3,342
Other restructuring associated costs	2,018	4,306	4,108	6,891
Asset-related charges	5,147	1,066	8,066	3,237
Other restructuring associated costs and asset-related charges	7,165	5,372	12,174	10,128
Total restructuring and asset-related charges, net	9,227	5,658	23,125	13,470
Operating segments | Europe
Restructuring Cost and Reserve
Restructuring severance and employee-related charges	3,877	1,706	7,275	2,793
Other restructuring associated costs	1,861	(1,191)	2,419	(1,191)
Asset-related charges	931	0	931	180
Other restructuring associated costs and asset-related charges	2,792	(1,191)	3,350	(1,011)
Total restructuring and asset-related charges, net	6,669	515	10,625	1,782
Corporate and Unallocated Costs
Restructuring Cost and Reserve
Restructuring severance and employee-related charges	355	639	560	826
Other restructuring associated costs	0	0	0	0
Asset-related charges	196	0	196	0
Other restructuring associated costs and asset-related charges	196	0	196	0
Total restructuring and asset-related charges, net	$ 551	$ 639	$ 756	$ 826

Restructuring and Asset-Relat_4

Restructuring and Asset-Related Charges - Restructuring Accrual (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023
Restructuring Reserve
Restructuring reserve, beginning balance	$ 3,375	$ 5,021
Current period charges	25,313	12,661
Payments	(15,586)	(15,067)
Currency translation	(206)	75
Restructuring reserve, ending balance	$ 12,896	$ 2,690

Restructuring and Asset-Relat_5

Restructuring and Asset-Related Charges - Narrative (Details) $ in Thousands			3 Months Ended			6 Months Ended		12 Months Ended
	Apr. 11, 2024 USD ($) manufacturingFacility	Jan. 26, 2023 USD ($)	Jun. 29, 2024 USD ($)	Sep. 30, 2023 manufacturingFacility	Jul. 01, 2023 USD ($)	Jun. 29, 2024 USD ($)	Jul. 01, 2023 USD ($)	Dec. 31, 2023 USD ($) manufacturingFacility	Dec. 31, 2022 USD ($)
Restructuring Cost and Reserve
Total cash outlays						$ 15,586	$ 15,067
Other restructuring associated costs			$ 3,879		$ 3,115	6,527	5,700
Restructuring Reserve			12,896		$ 2,690	12,896	$ 2,690	$ 3,375	$ 5,021
Current portion of restructuring accrual (Note 16)			12,896			12,896		$ 3,375
Facility Closing
Restructuring Cost and Reserve
Restructuring Reserve			8,600			8,600
Current portion of restructuring accrual (Note 16)			22,400			22,400
Facility Closing | North America
Restructuring Cost and Reserve
Number of manufacturing facilities to close | manufacturingFacility	2
Annual pre-tax income improvements	$ 11,000
Footprint Rationalization Efforts
Restructuring Cost and Reserve
Restructuring expenses			335			4,552
Total cash outlays			471			2,560
Manufacturing Facility Closure Plan
Restructuring Cost and Reserve
Restructuring expenses			12,651			21,471
Total cash outlays			5,679			5,679
Manufacturing Facility Closure Plan | Mexico
Restructuring Cost and Reserve
Number of manufacturing facilities to close | manufacturingFacility				2
Restructuring Reserve			1,400			1,400
Current portion of restructuring accrual (Note 16)			800			800
Manufacturing Facility Closure Plan | Capital expenditures
Restructuring Cost and Reserve
Restructuring expenses		$ 1,100
Manufacturing Facility Closure Plan | Facility Closing
Restructuring Cost and Reserve
Restructuring expenses		17,700
Total cash outlays		$ 12,900
European Operation Transformation
Restructuring Cost and Reserve
Restructuring expenses			6,228			11,360
Total cash outlays			4,864			8,943
Restructuring Reserve			3,200			3,200
Current portion of restructuring accrual (Note 16)			15,800			15,800
European Operation Transformation | Europe
Restructuring Cost and Reserve
Number of manufacturing facilities to close | manufacturingFacility								2
European Operation Transformation | Severance And Termination Charges | Europe
Restructuring Cost and Reserve
Restructuring expenses						8,200
European Operation Transformation | Severance And Termination Charges | Europe | Maximum
Restructuring Cost and Reserve
Restructuring expenses						27,500
European Operation Transformation | Capital expenditures
Restructuring Cost and Reserve
Restructuring expenses			$ 0			$ 1,264

Restructuring and Asset-Relat_6

Restructuring and Asset-Related Charges - Summary of Costs and Cash Outlays (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
	Jan. 26, 2023	Jun. 29, 2024	Jun. 29, 2024	Jul. 01, 2023
Restructuring Cost and Reserve
Total cash outlays			$ 15,586	$ 15,067
Manufacturing Facility Closure Plan
Restructuring Cost and Reserve
Restructuring expected cost		$ 37,800	37,800
Cost incurred to date		21,471	21,471
Total costs		12,651	21,471
Total cash outlays			28,100
Cumulative costs		5,679	5,679
Total cash outlays		5,679	5,679
Manufacturing Facility Closure Plan | Restructuring severance and employee-related charges
Restructuring Cost and Reserve
Restructuring expected cost		11,500	11,500
Cost incurred to date		10,546	10,546
Total costs		1,726	10,546
Manufacturing Facility Closure Plan | Other restructuring associated costs
Restructuring Cost and Reserve
Restructuring expected cost		7,600	7,600
Cost incurred to date		1,355	1,355
Total costs		1,355	1,355
Manufacturing Facility Closure Plan | Product-related cash charges
Restructuring Cost and Reserve
Restructuring expected cost		5,000	5,000
Cost incurred to date		2,649	2,649
Total costs		2,649	2,649
Manufacturing Facility Closure Plan | Total cash charges
Restructuring Cost and Reserve
Restructuring expected cost		24,100	24,100
Cost incurred to date		14,550	14,550
Total costs		5,730	14,550
Manufacturing Facility Closure Plan | Asset-related charges
Restructuring Cost and Reserve
Restructuring expected cost		9,300	9,300
Cost incurred to date		3,215	3,215
Total costs		3,215	3,215
Manufacturing Facility Closure Plan | Inventory and other product-related non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		4,400	4,400
Cost incurred to date		3,706	3,706
Total costs		3,706	3,706
Manufacturing Facility Closure Plan | Total non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		13,700	13,700
Cost incurred to date		6,921	6,921
Total costs		6,921	6,921
Manufacturing Facility Closure Plan | Capital expenditures
Restructuring Cost and Reserve
Total costs	$ 1,100
European Operation Transformation
Restructuring Cost and Reserve
Restructuring expected cost		27,500	27,500
Cost incurred to date		14,866	14,866
Total costs		6,228	11,360
Total cash outlays			26,900
Cumulative costs		11,058	11,058
Total cash outlays		4,864	8,943
European Operation Transformation | Restructuring severance and employee-related charges
Restructuring Cost and Reserve
Restructuring expected cost		19,200	19,200
Cost incurred to date		10,289	10,289
Total costs		3,825	7,207
European Operation Transformation | Other restructuring associated costs
Restructuring Cost and Reserve
Restructuring expected cost		4,400	4,400
Cost incurred to date		2,740	2,740
Total costs		1,830	2,316
European Operation Transformation | Total cash charges
Restructuring Cost and Reserve
Restructuring expected cost		23,600	23,600
Cost incurred to date		13,029	13,029
Total costs		5,655	9,523
European Operation Transformation | Asset-related non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		600	600
Cost incurred to date		573	573
Total costs		573	573
European Operation Transformation | Capital expenditures
Restructuring Cost and Reserve
Restructuring expected cost		3,300	3,300
Cost incurred to date		1,264	1,264
Total costs		0	1,264
Footprint Rationalization Efforts
Restructuring Cost and Reserve
Restructuring expected cost		18,700	18,700
Cost incurred to date		18,141	18,141
Total costs		335	4,552
Total cash outlays			10,600
Cumulative costs		9,187	9,187
Total cash outlays		471	2,560
Footprint Rationalization Efforts | Restructuring severance and employee-related charges
Restructuring Cost and Reserve
Restructuring expected cost		7,900	7,900
Cost incurred to date		7,502	7,502
Total costs		13	(311)
Footprint Rationalization Efforts | Other restructuring associated costs
Restructuring Cost and Reserve
Restructuring expected cost		2,700	2,700
Cost incurred to date		2,545	2,545
Total costs		322	1,944
Footprint Rationalization Efforts | Total cash charges
Restructuring Cost and Reserve
Restructuring expected cost		10,600	10,600
Cost incurred to date		10,047	10,047
Total costs		335	1,633
Footprint Rationalization Efforts | Asset-related charges
Restructuring Cost and Reserve
Restructuring expected cost		6,600	6,600
Cost incurred to date		6,628	6,628
Total costs		0	2,919
Footprint Rationalization Efforts | Inventory and other product-related non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		1,500	1,500
Cost incurred to date		1,466	1,466
Total costs		0	0
Footprint Rationalization Efforts | Total non-cash charges
Restructuring Cost and Reserve
Restructuring expected cost		8,100	8,100
Cost incurred to date		8,094	8,094
Total costs		$ 0	$ 2,919

Held for Sale (Details)

Held for Sale (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023
Assets
Liabilities held for sale	$ 4,800
Liabilities
Liabilities held for sale	200
Disposal Group, Held-for-sale, Not Discontinued Operations
Assets
Accounts receivable, net	42
Inventories	20,133
Other current assets	150
Property and equipment, net	57,965
Intangible assets, net	1,471
Goodwill	65,000
Operating lease assets, net	975
Liabilities held for sale	145,736
Liabilities
Accounts payable	65
Accrued payroll and benefits	1,239
Accrued expenses and other current liabilities	6,610
Operating lease liability	17
Liabilities held for sale	$ 7,931
Disposal Group, Held-for-sale, Not Discontinued Operations | Towanda
Assets
Accounts receivable, net		$ 0
Inventories		17,337
Other current assets		108
Property and equipment, net		50,672
Intangible assets, net		1,471
Goodwill		65,000
Operating lease assets, net		975
Liabilities held for sale		135,563
Liabilities
Accounts payable		0
Accrued payroll and benefits		901
Accrued expenses and other current liabilities		6,126
Operating lease liability		37
Liabilities held for sale		$ 7,064

Other (Income) Expense, Net - S

Other (Income) Expense, Net - Schedule of Other Expense (Income), Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Other Income and Expenses [Abstract]
JW Australia Transition Services Agreement cost recovery	$ (2,402)	$ 0	$ (6,542)	$ 0
Foreign currency losses (gains), net	632	(231)	(835)	(2,102)
Pension expense	513	1,657	1,028	3,351
Cash received on investment in real estate	(379)	0	(2,527)	0
Recovery of cost from receipts on impaired notes	0	(281)	(1,389)	(1,675)
Governmental assistance	(270)	(44)	(927)	(191)
Income from refund of deposits for China antidumping and countervailing duties	0	0	(2,947)	0
Insurance reimbursement	0	0	(1,655)	(1,234)
Other items, net	(582)	1,058	(957)	323
Total other income, net	$ (2,488)	$ 2,159	$ (16,751)	$ (1,528)

Other (Income) Expense, Net - N

Other (Income) Expense, Net - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Government Assistance [Line Items]
Governmental assistance	$ 270	$ 44	$ 927	$ 191

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) $ in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 29, 2024 USD ($)	Jul. 01, 2023 USD ($)	Jun. 29, 2024 USD ($)	Jul. 01, 2023 USD ($)	Feb. 29, 2024 USD ($)	Jun. 30, 2023 Rate	Apr. 18, 2023 AUD ($) Rate	May 31, 2020 USD ($)
Notional Disclosures
Realized gain (loss) on hedges	$ 0.3	$ 1.3	$ 0.7	$ 1
Forward contracts to sell a total							$ 420
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax
Amount expected to be reclassified to interest income over the next twelve months	$ 0.4		0.4
Minimum
Notional Disclosures
Exchange rate (USD per AUD) | Rate							67.51%
Maximum
Notional Disclosures
Exchange rate (USD per AUD) | Rate							67.59%
Designated as hedging instrument | Cash flow hedge
Notional Disclosures
Derivative fixed interest rate (as a percent)						0.317%
Foreign Exchange Contracts, Forecasted Transactions | Not Designated as Hedging Instrument
Notional Disclosures
Notional amount	70.9		70.9
Foreign Exchange Contracts, Foreign Currency Loans and Interest | Not Designated as Hedging Instrument
Notional Disclosures
Notional amount	83.9		83.9
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument
Notional Disclosures
Realized gain (loss) on hedges	0.2	$ (0.9)	1.5	0.1
Interest rate swap | Designated as hedging instrument | Cash flow hedge
Notional Disclosures
Notional amount								$ 370
Derivative fixed interest rate (as a percent)						0.317%		0.395%
Gains reclassified	$ 0.2	$ 4.3	$ 0.3	$ 8.1
Interest rate swap | Designated as hedging instrument | Cash flow hedge | Minimum | LIBOR
Notional Disclosures
Derivative variable interest rate (as a percent)						0.10%		0%
Interest Rate Cap | Designated as hedging instrument | Cash flow hedge
Notional Disclosures
Notional amount					$ 100			$ 370
Derivative fixed interest rate (as a percent)					4.50%
Interest Rate Cap | Designated as hedging instrument | Cash flow hedge | Minimum | SOFR
Notional Disclosures
Derivative variable interest rate (as a percent)					3.982%
Interest Rate Cap | Designated as hedging instrument | Cash flow hedge | Maximum | SOFR
Notional Disclosures
Derivative variable interest rate (as a percent)					3.895%

Derivative Financial Instrume_4

Derivative Financial Instruments - Fair Value (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023
Other current assets | Interest rate contracts | Derivatives designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative assets	$ 473	$ 0
Other current assets | Foreign currency forward contracts | Derivatives not designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative assets	491	1,186
Other current assets | Other derivative instruments | Derivatives not designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative assets	63	38
Deferred credits and other liabilities | Interest rate contracts | Derivatives designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative liabilities	37	0
Accrued expenses and other current liabilities | Foreign currency forward contracts | Derivatives not designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative liabilities	733	2,975
Accrued expenses and other current liabilities | Other derivative instruments | Derivatives not designated as hedging instruments:
Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Derivative liabilities	$ 0	$ 21

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 29, 2024	Dec. 31, 2023
Assets:
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Liabilities:
Derivative liabilities, recorded in accrued expenses and other current liabilities	$ 733	$ 2,996
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities (Note 8)	Accrued expenses and other current liabilities (Note 8)
Carrying Amount | Recurring
Assets:
Cash equivalents	$ 158,953	$ 71,139
Derivative assets, recorded in other current assets	1,027	1,224
Deferred compensation plan assets, recorded in other assets	4,485	2,098
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	1,219,521	1,232,780
Derivative liabilities, recorded in accrued expenses and other current liabilities	733	2,996
Derivative liability	37
Total Fair Value | Recurring
Assets:
Cash equivalents	158,953	71,139
Derivative assets, recorded in other current assets	1,027	1,224
Deferred compensation plan assets, recorded in other assets	4,485	2,098
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	1,196,522	1,209,961
Derivative liabilities, recorded in accrued expenses and other current liabilities	733	2,996
Derivative liability	37
Total Fair Value | Recurring | Level 1
Assets:
Cash equivalents	158,953	71,139
Derivative assets, recorded in other current assets	0	0
Deferred compensation plan assets, recorded in other assets	0	0
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	0	0
Derivative liabilities, recorded in accrued expenses and other current liabilities	0	0
Derivative liability	0
Total Fair Value | Recurring | Level 2
Assets:
Cash equivalents	0	0
Derivative assets, recorded in other current assets	1,027	1,224
Deferred compensation plan assets, recorded in other assets	4,485	2,098
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	1,196,522	1,209,961
Derivative liabilities, recorded in accrued expenses and other current liabilities	733	2,996
Derivative liability	37
Total Fair Value | Recurring | Level 3
Assets:
Cash equivalents	0	0
Derivative assets, recorded in other current assets	0	0
Deferred compensation plan assets, recorded in other assets	0	0
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt	0	0
Derivative liabilities, recorded in accrued expenses and other current liabilities	0	$ 0
Derivative liability	$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions

1 Months Ended

6 Months Ended

Nov. 03, 2021

Feb. 18, 2021

Nov. 19, 2019

Apr. 12, 2019

Mar. 13, 2019

May 11, 2018

Jan. 31, 2023

Feb. 28, 2018

Jun. 29, 2024

Mar. 30, 2024

Dec. 31, 2023

Dec. 31, 2021

Loss Contingencies

Accrued self-insurance liability

$ 88.8

$ 89.2

Financing bonds and letters of credit

$ 72.2

$ 68.7

Environmental Loss Contingency, Current, Statement of Financial Position [Extensible Enumeration]

Accrued expenses and other current liabilities (Note 8)

Accrued expenses and other current liabilities (Note 8)

Environmental loss contingencies, current

$ 0

$ 0.5

Environmental Loss Contingency, Noncurrent, Statement of Financial Position [Extensible Enumeration]

Deferred credits and other liabilities

Deferred credits and other liabilities

Environmental loss contingencies, non-current

$ 11.5

$ 11.5

Preferred remedial alternatives totaling

$ 23.4

PaDEP

Loss Contingencies

Collateralized bond

$ 1.4

$ 1.4

Minimum

Loss Contingencies

Environmental remedial feasibility alternative

11.8

Minimum | Domestic Product Liability

Loss Contingencies

Concentration risk, auto, employee and general liability

5

Minimum | Auto, General Liability, Personal Injury and Workers Compensation

Loss Contingencies

Concentration risk, auto, employee and general liability

3

Maximum

Loss Contingencies

Environmental remedial feasibility alternative

$ 33.4

Maximum | Domestic Product Liability

Loss Contingencies

Concentration risk, auto, employee and general liability

200

Maximum | Auto, General Liability, Personal Injury and Workers Compensation

Loss Contingencies

Concentration risk, auto, employee and general liability

$ 200

Steve and Sons

Loss Contingencies

Damages awarded to plaintiff

$ 36.5

$ 7.1

$ 36.5

Settlement proceeds awarded

$ 1.2

Damages sought

$ 139.4

Steve and Sons | Attorney Fees

Loss Contingencies

Damages sought

$ 28.4

Steve and Sons | Legal Cost

Loss Contingencies

Damages sought

$ 1.7

Direct Purchaser Action

Loss Contingencies

Proceeds from legal settlements

$ 10.5

Past Damages | Steve and Sons

Loss Contingencies

Damages awarded to plaintiff

9.9

$ 12.2

Future Damages | Steve and Sons

Loss Contingencies

Damages awarded to plaintiff

$ 139.4

$ 46.5

Loss contingency accrual, payments

$ 66.4

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023
Cash Operating Activities:
Operating leases	$ 24,622	$ 29,970
Interest payments on financing lease obligations	225	106
Cash paid for amounts included in the measurement of lease liabilities	24,847	30,076
Cash Investing Activities:
Purchases of securities for deferred compensation plan	(2,817)	(770)
Sale of securities for deferred compensation plan	0	111
Change in securities for deferred compensation plan	(2,817)	(659)
Cash received for notes receivable	2	0
Change in notes receivable	2	0
Non-cash Investing Activities:
Property, equipment, and intangibles purchased in accounts payable	12,698	5,591
Property, equipment, and intangibles purchased with debt	3,518	7,405
Customer accounts receivable converted to notes receivable	10	96
Cash Financing Activities:
Borrowings on long-term debt	1,225	126,933
Payments of long-term debt	(16,803)	(197,259)
Payments of debt issuance and extinguishment costs, including underwriting fees	(198)	0
Change in long-term debt and payments of debt extinguishment costs	(15,776)	(70,326)
Cash paid for amounts included in the measurement of finance lease liabilities	1,195	985
Non-cash Financing Activities:
Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities	0	732
Accounts payable converted to installment notes	5	176
Other Supplemental Cash Flow Information:
Cash taxes paid, net of refunds	17,332	25,839
Cash interest paid	$ 39,520	$ 41,859